<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-05-29</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38807265/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">Sodium signal intensity of CSF using 1H-guided 23Na-MRI as a potential noninvasive biomarker in Alzheimer&#39;s disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38807265-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Our study provides evidence that rSSI in CSF is increased in AD patients in comparison to healthy controls. rSSI may serve as a potential marker for early detection and monitoring of disease progression. Larger, longitudinal studies are needed to confirm our findings and to investigate the association between rSSI in CSF and the severity of cognitive &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38807558/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">Prognostic factors for surgical treatment of radiation-induced scleral necrosis after brachytherapy for uveal melanoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38807558-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In our series, about the half of RISN cases underwent surgical treatment. The presented novel severity scale for RISN might become a helpful tool for clinical management of individuals with RISN. We recommend external validation of the diagnostic accuracy of the presented &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38808605/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">Maternal age is related to offspring DNA methylation: A meta-analysis of results from the PACE consortium</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38808605-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Worldwide trends to delay childbearing have increased parental ages at birth. Older parental age may harm offspring health, but mechanisms remain unclear. Alterations in offspring DNA methylation (DNAm) patterns could play a role as aging has been associated with methylation changes in gametes of older individuals. We meta-analyzed epigenome-wide associations of parental age with offspring blood DNAm of over 9500 newborns and 2000 children (5-10 years old) from the Pregnancy and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38808744/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">The IPTA Nashville consensus conference on post-transplant lymphoproliferative disorders after solid organ transplantation in children: IV-consensus guidelines for the management of post-transplant lymphoproliferative disorders in children and adolescents</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38808744-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The International Pediatric Transplant Association convened an expert consensus conference to assess current evidence and develop recommendations for various aspects of care relating to post-transplant lymphoproliferative disorders (PTLD) after pediatric solid organ transplantation. This report addresses the outcomes of deliberations by the PTLD Management Working Group. A strong recommendation was made for reduction in immunosuppression as the first step in management. Similarly, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38808905/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">Alternative approaches to analyzing ventilator-free days, mortality and duration of ventilation in critical care research</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38808905-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: In this study, we describe the relative power of new methods for analyzing ventilator-free days in critical care research. Our data provide validation and guidance for the use of the cumulative logistic model, median regression, generalized pairwise comparisons, and the conditional and truncated approach in specific &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38809160/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">ï»¿Ethical Considerations of Including Minors in Clinical Trials Using the Example of the Indicated Prevention of Psychotic Disordersï»¿</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38809160-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Ethical Considerations of Including Minors in Clinical Trials Using the Example of the Indicated Prevention of Psychotic Disorders Abstract: As a vulnerable group, minors require special protection in studies. For this reason, researchers are often reluctant to initiate studies, and ethics committees are reluctant to authorize such studies. This often excludes minors from participating in clinical studies. This exclusion can lead to researchers and clinicians receiving only incomplete data &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38809174/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240529181055&amp;v=2.18.0.post9&#43;e462414">Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38809174-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240529181055-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In patients with mixed hyperlipidemia, zodasiran was associated with significant decreases in triglyceride levels at 24 weeks. (Funded by Arrowhead Pharmaceuticals; ARCHES-2 ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38809176/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240529181055&amp;v=2.18.0.post9&#43;e462414">Exceptional Genetics, Generalizable Therapeutics, and Coronary Artery Disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38809176-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240529181055-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38809279/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">The radiomorphological appearance of the invasive margin in pancreatic cancer is associated with tumor budding</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38809279-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Our study identifies a readily available radiological marker for non-invasive estimation of tumor budding, as a correlate for infiltrative tumor growth. This finding could help to identify PDAC patients who might benefit from more extensive peripancreatic soft tissue resection during surgery or stratify patients for personalized therapy &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38809374/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">Understanding Differences in Sex-Based Outcomes with Dual Antiplatelet Therapy After Percutaneous Coronary Intervention</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38809374-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgA26BjBg">ğŸ”»ä»Šå¤©çš„åŠ æ²™å…¨å›¾ï¼Œç”±Gaza war unité¡¹ç›®ç»„åˆ¶ä½œã€‚ğŸ”»ä»Šå¤©ï¼Œä»¥å†›çš„ç¬¬ 98 å¸ˆç¦»å¼€äº†åŠ æ²™åœ°å¸¦ï¼Œç»“æŸäº†å¯¹è´¾å·´é‡Œäºšéš¾æ°‘è¥çš„çªè¢­ã€‚ è¿™æ„å‘³ç€ç¬¬ 7 æ—…ã€ç¬¬ 35 æ—…å’Œç¬¬ 46...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oga26bjbg/">
    
    
    
    
    
      
    
    ğŸ”»ä»Šå¤©çš„åŠ æ²™å…¨å›¾ï¼Œç”±Gaza war unité¡¹ç›®ç»„åˆ¶ä½œã€‚<!-- raw HTML omitted -->ğŸ”»ä»Šå¤©ï¼Œä»¥å†›çš„ç¬¬ 98 å¸ˆç¦»å¼€äº†åŠ æ²™åœ°å¸¦ï¼Œç»“æŸäº†å¯¹è´¾å·´é‡Œäºšéš¾æ°‘è¥çš„çªè¢­ã€‚ è¿™æ„å‘³ç€ç¬¬ 7 æ—…ã€ç¬¬ 35 æ—…å’Œç¬¬ 460 æ—…å·²æ’¤å‡ºåŠ æ²™ã€‚é¢„è®¡ç¬¬ 7 æ—…å’Œç¬¬ 35 æ—…å°†åœ¨æœªæ¥å‡ å¤©å†…ä¸ç¬¬ 98 å¸ˆä¸€èµ·è½¬ç§»åˆ°æ‹‰æ³•ï¼Œè€Œç¬¬ 460 æ—…å°†è¿”å›å†…ç›–å¤«åŸºåœ°ï¼ˆå› ä¸ºå®ƒæ˜¯ä¸€ä¸ªè®­ç»ƒæ—…ï¼‰ã€‚<!-- raw HTML omitted -->ğŸ”»åŠ æ²™å…¨å¢ƒä»æœ‰ 7 ä¸ªæ—…ï¼Œå…¶ä¸­ 2 ä¸ªéš¶å±äºå†…æ‰æ—çš„ç¬¬ 99 å¸ˆï¼Œ5 ä¸ªéš¶å±äºæ‹‰æ³•çš„ç¬¬ 162 å¸ˆã€‚<!-- raw HTML omitted -->ğŸ”»æ‰€ä»¥ï¼Œå›¾1ä¸­ï¼Œè“è‰²ä¸ºä»¥å†›ç°åœ¨çš„æ§åˆ¶åŒºã€‚<!-- raw HTML omitted -->ğŸ”»æ˜¯çš„ï¼Œç»è¿‡å…«ä¸ªæœˆçš„æˆ˜æ–—ï¼Œå“ˆé©¬æ–¯ä¾ç„¶æ§åˆ¶ç€åŠ æ²™çš„å¤§å¤šæ•°åœ°åŒºã€‚<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%B7%B4%E8%A5%BF%E6%80%BB%E7%BB%9F%E5%AE%A3%E5%B8%83%E6%B0%B8%E4%B9%85%E6%92%A4%E5%9B%9E%E9%A9%BB%E4%BB%A5%E8%89%B2%E5%88%97%E5%A4%A7%E4%BD%BF">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%B7%B4%E8%A5%BF%E6%80%BB%E7%BB%9F%E5%AE%A3%E5%B8%83%E6%B0%B8%E4%B9%85%E6%92%A4%E5%9B%9E%E9%A9%BB%E4%BB%A5%E8%89%B2%E5%88%97%E5%A4%A7%E4%BD%BF</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgA3DrsyD">è¿™èˆ¹çš„é€‰é…æ„Ÿè§‰å¾ˆå‡‘åˆå•Šã€‚ - è½¬å‘ @ç–¯å­ç™½æ¨:&amp;ensp;åœŸè€³å…¶ä¸ºä¸ºä¹Œå…‹å…°å»ºé€ çš„F 211â€œä¼Šä¸‡Â·é©¬æ³½å¸•é…‹é•¿â€å·æŠ¤å«èˆ°å¼€å§‹æµ·è¯• [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oga3drsyd/">
    
    
    
    
    
      
    
    è¿™èˆ¹çš„é€‰é…æ„Ÿè§‰å¾ˆå‡‘åˆå•Šã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@ç–¯å­ç™½æ¨<!-- raw HTML omitted -->:â€‚åœŸè€³å…¶ä¸ºä¸ºä¹Œå…‹å…°å»ºé€ çš„F 211â€œä¼Šä¸‡Â·é©¬æ³½å¸•é…‹é•¿â€å·æŠ¤å«èˆ°å¼€å§‹æµ·è¯• <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgA5Boeag">ğŸ”»æ™šå®‰ã€‚ğŸ”»å¦‚æœä½ è§‰å¾—å·¥ä½œå’Œç”Ÿæ´»ç³Ÿç³•ï¼Œä¸å¦‚æƒ³æƒ³è¿™ä¸ªæœºæˆ¿çš„ç½‘ç®¡ã€‚</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oga5boeag/">
    
    
    
    
    
      
    
    ğŸ”»æ™šå®‰ã€‚<!-- raw HTML omitted -->ğŸ”»å¦‚æœä½ è§‰å¾—å·¥ä½œå’Œç”Ÿæ´»ç³Ÿç³•ï¼Œä¸å¦‚æƒ³æƒ³è¿™ä¸ªæœºæˆ¿çš„ç½‘ç®¡ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/y4zMdqrIlx08ff73OYFO010412008PF70E010.mp4?label=mp4_ld&amp;amp;template=356x640.24.0&amp;amp;ori">https://f.video.weibocdn.com/o0/y4zMdqrIlx08ff73OYFO010412008PF70E010.mp4?label=mp4_ld&amp;amp;template=356x640.24.0&amp;amp;ori</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgA6i6h0P">ğŸ”»æ’æ’­ã€‚#å·´è¥¿æ€»ç»Ÿå®£å¸ƒæ°¸ä¹…æ’¤å›é©»ä»¥è‰²åˆ—å¤§ä½¿# [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oga6i6h0p/">
    
    
    
    
    
      
    
    ğŸ”»æ’æ’­ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å·´è¥¿æ€»ç»Ÿå®£å¸ƒæ°¸ä¹…æ’¤å›é©»ä»¥è‰²åˆ—å¤§ä½¿#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/639b1bfbly1hq6u0f8fzij20q80qyake.jpg%22">https://tvax1.sinaimg.cn/large/639b1bfbly1hq6u0f8fzij20q80qyake.jpg&quot;</a> referrerpolicy=&ldquo;no-refer &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgAWJDtXW">ğŸ”»571 å¹´å‰çš„ä»Šå¤©ï¼Œå¥¥æ–¯æ›¼ç¦å«å†›ç¿»è¶Šäº†ç‹„å¥¥å¤šè¥¿å¢™ã€‚ ğŸ”»çƒ­é‚£äºšäººçš„é¦–é¢†ä¹”ç“¦å°¼-æœ±æ–¯è’‚å°¼äºšå°¼å—ä¼¤åé€ƒè·‘äº†ã€‚å›å£«å¦ä¸åä¸€ä¸–æŠ•å…¥äº†è¿™åœºæ¯«æ— å¸Œæœ›çš„æˆ˜æ–—ï¼Œå¸¦é¢†ä»–çš„...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogawjdtxw/">
    
    
    
    
    
      
    
    ğŸ”»571 å¹´å‰çš„ä»Šå¤©ï¼Œå¥¥æ–¯æ›¼ç¦å«å†›ç¿»è¶Šäº†ç‹„å¥¥å¤šè¥¿å¢™ã€‚ <!-- raw HTML omitted -->ğŸ”»çƒ­é‚£äºšäººçš„é¦–é¢†ä¹”ç“¦å°¼-æœ±æ–¯è’‚å°¼äºšå°¼å—ä¼¤åé€ƒè·‘äº†ã€‚å›å£«å¦ä¸åä¸€ä¸–æŠ•å…¥äº†è¿™åœºæ¯«æ— å¸Œæœ›çš„æˆ˜æ–—ï¼Œå¸¦é¢†ä»–çš„éƒ¨ä¸‹å‘èµ·äº†æœ€åçš„å†²é”‹ã€‚<!-- raw HTML omitted -->ğŸ”»ä¸­ä¸–çºªç»“æŸäº†ã€‚<!-- raw HTML omitted -->ğŸ”»ç²¾ç½—å¿«çˆ†å“­ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg">https://tvax2.sinaimg</a>. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgzI2aJOB">ğŸ”»CNNé‡‡è®¿ä¹Œå…‹å…°å£«å…µï¼šâ€œè‰¾å¸ƒæ‹‰å§†æ–¯å…¶å®å¾ˆçƒ‚ï¼å®ƒçš„è£…ç”²ä¸è¶³ä»¥é€‚åº”è¿™ä¸ªæ—¶ä»£ã€‚æœ‰ä¸€æ¬¡ï¼Œæˆ‘ä»¬å‘ä¸€æ ‹æˆ¿å­æ‰“äº†17å‘ï¼Œä½†å®ƒä»ç„¶å±¹ç«‹ä¸å€’ã€‚â€ğŸ”»6ğŸ”»ä½ ä»¬ç¾å›½æ˜¯ä¸æ˜¯çœŸ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogzi2ajob/">
    
    
    
    
    
      
    
    ğŸ”»CNNé‡‡è®¿ä¹Œå…‹å…°å£«å…µï¼šâ€œè‰¾å¸ƒæ‹‰å§†æ–¯å…¶å®å¾ˆçƒ‚ï¼å®ƒçš„è£…ç”²ä¸è¶³ä»¥é€‚åº”è¿™ä¸ªæ—¶ä»£ã€‚æœ‰ä¸€æ¬¡ï¼Œæˆ‘ä»¬å‘ä¸€æ ‹æˆ¿å­æ‰“äº†17å‘ï¼Œä½†å®ƒä»ç„¶å±¹ç«‹ä¸å€’ã€‚â€<!-- raw HTML omitted -->ğŸ”»6<!-- raw HTML omitted -->ğŸ”»ä½ ä»¬ç¾å›½æ˜¯ä¸æ˜¯çœŸçš„æœ‰æˆ˜å¿½å±€å•Šï¼Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax3.sinaimg.cn/orj480/639b1bfbly1hq6s8639kaj20zk0k0wff.jpg%22">https://tvax3.sinaimg.cn/orj480/639b1bfbly1hq6s8639kaj20zk0k0wff.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgzMkvx4T">ğŸ”»éŸ©å›½è¯´ï¼Œä¸€å…±é£˜è¿‡æ¥150ä¸ªğŸ’©æ°”çƒã€‚æœ‰äº›è¿˜å¸¦æœ‰å®šæ—¶è£…ç½®ï¼Œå¯ä»¥åœ¨ç©ºä¸­å°±æŠŠğŸ’©è¢‹å­ç»™ç‚¸å¼€ã€‚ğŸ”»ç”±äºå®³æ€•å…¶ä¸­çš„ä¸œè¥¿æœ‰å®³ï¼ŒéŸ©å›½å†›è­¦ä¸å¾—ä¸äº²æ‰‹æ¸…ç†è¿™äº›ä¸œè¥¿â€¦â€¦#...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogzmkvx4t/">
    
    
    
    
    
      
    
    ğŸ”»éŸ©å›½è¯´ï¼Œä¸€å…±é£˜è¿‡æ¥150ä¸ªğŸ’©æ°”çƒã€‚æœ‰äº›è¿˜å¸¦æœ‰å®šæ—¶è£…ç½®ï¼Œå¯ä»¥åœ¨ç©ºä¸­å°±æŠŠğŸ’©è¢‹å­ç»™ç‚¸å¼€ã€‚<!-- raw HTML omitted -->ğŸ”»ç”±äºå®³æ€•å…¶ä¸­çš„ä¸œè¥¿æœ‰å®³ï¼ŒéŸ©å›½å†›è­¦ä¸å¾—ä¸äº²æ‰‹æ¸…ç†è¿™äº›ä¸œè¥¿â€¦â€¦<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#æœé²œç”¨æ°”çƒå‘éŸ©å›½æŠ•æ”¾å¤§é‡åºŸçº¸å’Œæ±¡ç‰©#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgzN3qrGu">ğŸ”»ä½†æ˜¯å˜‰å³ªå…³ä¹Ÿä¸æ˜¯å‡­ç©ºå†’å‡ºæ¥å°±è¿™ä¹ˆæ¼‚äº®çš„å°åŸã€‚ğŸ”»ç¤¾ä¼šä¸»ä¹‰æ˜¯å¹²å‡ºæ¥çš„ï¼Œä¸å¹²ï¼ŒåŠç‚¹ç¤¾ä¼šä¸»ä¹‰æ²¡æœ‰ã€‚#å®˜æ–¹ç¡®è®¤ä¸æ»¡å˜‰å³ªå…³æ­¦å¤§é€‰è°ƒç”Ÿç¦»èŒ# [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogzn3qrgu/">
    
    
    
    
    
      
    
    ğŸ”»ä½†æ˜¯å˜‰å³ªå…³ä¹Ÿä¸æ˜¯å‡­ç©ºå†’å‡ºæ¥å°±è¿™ä¹ˆæ¼‚äº®çš„å°åŸã€‚<!-- raw HTML omitted -->ğŸ”»ç¤¾ä¼šä¸»ä¹‰æ˜¯å¹²å‡ºæ¥çš„ï¼Œä¸å¹²ï¼ŒåŠç‚¹ç¤¾ä¼šä¸»ä¹‰æ²¡æœ‰ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å®˜æ–¹ç¡®è®¤ä¸æ»¡å˜‰å³ªå…³æ­¦å¤§é€‰è°ƒç”Ÿç¦»èŒ#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/6">https://tvax3.sinaimg.cn/large/6</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgzPVo4tk">â€œè¿™è¾†è‰¾å¸ƒæ‹‰å§†æ–¯åˆšä»æ³¢å…°è¿æ¥ï¼Œå°±å·²ç»åäº†â€ã€‚è¯ä¸èƒ½è¿™ä¹ˆè¯´ï¼Œå¹³è´¦çš„æ—¶å€™è‚¯å®šä¸æ˜¯æŒ‰åçš„ç®—çš„ã€‚ - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»CNNé‡‡è®¿ä¹Œå…‹å…°å£«å…µï¼šâ€œè‰¾å¸ƒæ‹‰...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogzpvo4tk/">
    
    
    
    
    
      
    
    â€œè¿™è¾†è‰¾å¸ƒæ‹‰å§†æ–¯åˆšä»æ³¢å…°è¿æ¥ï¼Œå°±å·²ç»åäº†â€ã€‚è¯ä¸èƒ½è¿™ä¹ˆè¯´ï¼Œå¹³è´¦çš„æ—¶å€™è‚¯å®šä¸æ˜¯æŒ‰åçš„ç®—çš„ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»CNNé‡‡è®¿ä¹Œå…‹å…°å£«å…µï¼šâ€œè‰¾å¸ƒæ‹‰å§†æ–¯å…¶å®å¾ˆçƒ‚ï¼å®ƒçš„è£…ç”²ä¸è¶³ä»¥é€‚åº”è¿™ä¸ªæ—¶ä»£ã€‚æœ‰ä¸€æ¬¡ï¼Œæˆ‘ä»¬å‘ä¸€æ ‹æˆ¿å­æ‰“äº†17å‘ï¼Œä½†å®ƒä»ç„¶å±¹ç«‹ä¸å€’ã€‚â€<!-- raw HTML omitted -->ğŸ”»6<!-- raw HTML omitted -->ğŸ”»ä½ ä»¬ç¾å›½æ˜¯ä¸æ˜¯çœŸçš„æœ‰æˆ˜å¿½å±€å•Šï¼Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgzUqrniM">ğŸ”»ä»€ä¹ˆæ˜¯é€‰è°ƒç”Ÿï¼Ÿå°±æ˜¯ç»å„çœå¸‚åŒºç»„ç»‡éƒ¨é—¨æœ‰è®¡åˆ’ä»é«˜æ ¡é€‰è°ƒåˆ°åŸºå±‚é‡ç‚¹åŸ¹å…»çš„ç¾¤ä½“ï¼Œ åœ¨åŸºå±‚â€œå¤§èˆå°â€ä¸Šæ¼”é’æ˜¥â€œå¹³å‡¡æˆâ€çš„å¹´è½»äººã€‚ğŸ”»åˆ°åŸºå±‚å·¥ä½œé”»ç‚¼ï¼Œæ˜¯é€‰è°ƒ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogzuqrnim/">
    
    
    
    
    
      
    
    ğŸ”»ä»€ä¹ˆæ˜¯é€‰è°ƒç”Ÿï¼Ÿå°±æ˜¯ç»å„çœå¸‚åŒºç»„ç»‡éƒ¨é—¨æœ‰è®¡åˆ’ä»é«˜æ ¡é€‰è°ƒåˆ°åŸºå±‚é‡ç‚¹åŸ¹å…»çš„ç¾¤ä½“ï¼Œ åœ¨åŸºå±‚â€œå¤§èˆå°â€ä¸Šæ¼”é’æ˜¥â€œå¹³å‡¡æˆâ€çš„å¹´è½»äººã€‚<!-- raw HTML omitted -->ğŸ”»åˆ°åŸºå±‚å·¥ä½œé”»ç‚¼ï¼Œæ˜¯é€‰è°ƒç”Ÿçš„å¿…ç»ä¹‹è·¯ã€‚<!-- raw HTML omitted -->ğŸ”»æˆ‘ä»¬ä¹‹æ‰€ä»¥å¥½ï¼Œå°±å¥½åœ¨å®°ç›¸å¿…èµ·äºå·éƒ¡ï¼ŒçŒ›å°†å¿…å‘äºå’ä¼ï¼Œå¹¶ä¸”èƒ½ä¸€ç›´åšæŒä¸‹å»ï¼Œè€å˜´çš®å­çš„é”®ç›˜ä¾ ä¸€è¾ˆå­æ‘¸ä¸åˆ°å†³ç­–çš„é—¨ï¼Œæ­¤ä¹ƒé•¿èƒœä¹‹é“ã€‚<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%AE%98%E6%96%B9%E7%A1%AE%E8%AE%A4%E4%B8%8D%E6%BB%A1%E5%98%89%E5%B3%AA%E5%85%B3%E6%AD%A6%E5%A4%A7%E9%80%89%E8%B0%83%E7%94%9F%E7%A6%BB%E8%81%8C%23&amp;amp;extparam=%23%E5%AE%98%E6%96%B9%E7%A1%AE%E8%AE%A4%E4%B8%8D%E6%BB%A1%E5%98%89%E5%B3%AA%E5%85%25B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%AE%98%E6%96%B9%E7%A1%AE%E8%AE%A4%E4%B8%8D%E6%BB%A1%E5%98%89%E5%B3%AA%E5%85%B3%E6%AD%A6%E5%A4%A7%E9%80%89%E8%B0%83%E7%94%9F%E7%A6%BB%E8%81%8C%23&amp;amp;extparam=%23%E5%AE%98%E6%96%B9%E7%A1%AE%E8%AE%A4%E4%B8%8D%E6%BB%A1%E5%98%89%E5%B3%AA%E5%85%B</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/OgxKx5or2">çœŸå±ˆè¾±å•Šå¦ˆçš„</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-ogxkx5or2/">
    
    
    
    
    
      
    
    çœŸå±ˆè¾±å•Šå¦ˆçš„  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Ogvpe4obA">å ‚å§å¤«å¦‡å¹´å±Šå…«æ—¬ï¼Œåœ¨æµ·å£çŒ«å†¬ã€‚æˆ‘ä»¬çº¢å®çŸ³å©šèœœæœˆä¹‹æ—…è‡³æµ·å£çš„æ—¶å€™ï¼Œæ›¾å»çœ‹æœ›è¿‡ä»–ä»¬ã€‚æ˜¥å¤©çš„æ—¶å€™ï¼Œä»–ä»¬åˆå›æˆéƒ½äº†ï¼Œå–µå¥¶å¥¶æƒ³è¯·ä»–ä»¬åƒä¸ªé¥­ï¼Œè¯´äº†å¥½ä¹…ï¼Œéƒ½æ²¡å®šä¸‹æ¥...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ogvpe4oba/">
    
    
    
    
    
      
    
    å ‚å§å¤«å¦‡å¹´å±Šå…«æ—¬ï¼Œåœ¨æµ·å£çŒ«å†¬ã€‚æˆ‘ä»¬çº¢å®çŸ³å©šèœœæœˆä¹‹æ—…è‡³æµ·å£çš„æ—¶å€™ï¼Œæ›¾å»çœ‹æœ›è¿‡ä»–ä»¬ã€‚æ˜¥å¤©çš„æ—¶å€™ï¼Œä»–ä»¬åˆå›æˆéƒ½äº†ï¼Œå–µå¥¶å¥¶æƒ³è¯·ä»–ä»¬åƒä¸ªé¥­ï¼Œè¯´äº†å¥½ä¹…ï¼Œéƒ½æ²¡å®šä¸‹æ¥ã€‚æˆ‘ä»¬ä¸‹å‘¨å°±è¦å‡ºé—¨æ—…æ¸¸ï¼Œä¸èƒ½å†æ‹–ï¼Œå°±å®šåœ¨ä»Šå¤©ã€‚æˆ‘è¯´å»åƒæ¨ä¸‰å­ƒç¿˜è„šç‰›è‚‰è¿˜æ˜¯è‡ªè´¡èœï¼Ÿå¥¹è¯´å°±åœ¨å®¶é‡Œåƒï¼Œæˆ‘è¯´å¤ªéº»çƒ¦äº†ã€‚å¥¹è¯´åœ¨å®¶é‡Œåƒæ‰æœ‰æ°”æ°›ï¼Œæˆ‘è¯´å…³é”®æ˜¯ä»–ä»¬å¿Œè®³å¤šï¼Œè‚¥è‚‰ä¸èƒ½åƒï¼Œæ²¹ç‚¸çš„ä¸èƒ½åƒï¼Œå‘³ç²¾ä¸èƒ½åƒï¼Œæ²¹å¤ªå¤šä¸èƒ½åƒï¼Œæˆ‘çš„å¨è‰ºæ— ç”¨æ­¦ä¹‹åœ°ã€‚å¥¹è¯´ä½ ä¸æ™“å¾—ä¸æ”¾å‘³ç²¾å°‘æ”¾æ²¹ï¼Ÿæˆ‘è¯´å¦‚æœè¿™æ ·ï¼Œé‚£å°±ä¸è¦æ€ªæˆ‘åšå¾—ä¸å¥½åƒã€‚å¥¹è¯´å¥½ä¸å¥½åƒæ— æ‰€è°“ï¼Œä¸»è¦æ˜¯è®©å§å¤«æ¥çœ‹çœ‹ï¼Œä»–æ˜¯æ•™æˆï¼Œä½ ä¹Ÿæ˜¯æ•™æˆï¼Œä½ ä¼šåšé¥­ï¼Œä»–ä¸ºä»€ä¹ˆä¸èƒ½åšï¼ŸåŸæ¥ï¼Œå ‚å§å¤«ä¸å–œæ¬¢åšå®¶åŠ¡æ´»ï¼Œå–µå¥¶å¥¶è¯·ä»–ä»¬æ¥å®¶åƒé¥­ï¼Œç›®çš„æ˜¯æƒ³ç»™ä»–ä¸€ä¸ªç¤ºèŒƒæ•™è‚²ï¼Œå­¦ä¹ åšå®¶åŠ¡æ´»ã€‚ æˆ‘è¯´å¹´è½»çš„æ—¶å€™ä¸å­¦ï¼Œç°åœ¨è€äº†ï¼Œç¬¨æ‰‹ç¬¨è„šï¼Œå’‹ä¸ªå­¦å˜›ï¼Ÿå¥¹è¯´ä½ æœ€è¿‘å¾®åšæ‰è½¬å‘çš„åŒ—å¤§åŒ»å­¦ä¸“å®¶æ„è§ï¼Œåšå®¶åŠ¡æ´»å¯ä»¥é¢„é˜²è€å¹´ç—´å‘†å¾—å˜›ï¼ä½ ä»Šå¤©å°±è·Ÿä»–è¯´ä¸€è¯´ã€‚ &lt;a href=&ldquo;<a href="http://weibo.com/p/100101B209475">http://weibo.com/p/100101B209475</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Ogzoyj1Tz">å–µçˆ·çˆ·ç¡•å£«ç ”ç©¶ç”Ÿæ¯æ ¡å·å¸ˆå¤§æ˜¯â€œåŒéâ€é™¢æ ¡ï¼Œåœ¨ä¸­å›½é«˜æ ¡æ’è¡Œæ¦œï¼Œå¯èƒ½åœ¨ä¸¤ä¸‰ç™¾åä¹‹åï¼Œä¸å±‘ä¸€æï¼Œä½†æˆ‘å¯¹å·å¸ˆå¤§æƒ…æœ‰ç‹¬é’Ÿã€‚ç¬¬ä¸€ï¼Œæˆ‘åœ¨é‚£é‡Œæ‰¾åˆ°äº†å–µå¥¶å¥¶ï¼›ç¬¬äºŒï¼Œæˆ‘åœ¨...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ogzoyj1tz/">
    
    
    
    
    
      
    
    å–µçˆ·çˆ·ç¡•å£«ç ”ç©¶ç”Ÿæ¯æ ¡å·å¸ˆå¤§æ˜¯â€œåŒéâ€é™¢æ ¡ï¼Œåœ¨ä¸­å›½é«˜æ ¡æ’è¡Œæ¦œï¼Œå¯èƒ½åœ¨ä¸¤ä¸‰ç™¾åä¹‹åï¼Œä¸å±‘ä¸€æï¼Œä½†æˆ‘å¯¹å·å¸ˆå¤§æƒ…æœ‰ç‹¬é’Ÿã€‚ç¬¬ä¸€ï¼Œæˆ‘åœ¨é‚£é‡Œæ‰¾åˆ°äº†å–µå¥¶å¥¶ï¼›ç¬¬äºŒï¼Œæˆ‘åœ¨é‚£é‡Œæ‰¾åˆ°äº†äººç”Ÿå¿«ä¹çš„çœŸè°›ï¼Œè€Œä¸”æŠŠè¿™ç§å¿«ä¹çœŸè°›å¸¦åˆ°äº†â€œ211â€â€œ985â€é«˜æ ¡â€”â€”åŒ—äº¬å¸ˆå¤§ã€‚è§å¤©æ¶¯æ—§æ–‡ã€Šå…»çŒªè®°ã€‹å’Œã€Šå…»çŒªç»­è®°ã€‹ã€‚è¿™ä¸¤ç¯‡æ—§æ–‡ä¸­çš„äººç‰©ï¼Œæˆ–æ¸…ååŒ—å¤§æ•™æˆé•¿æ±Ÿå­¦è€…ï¼Œæˆ–ç¤¾ä¼šè¾¹ç¼˜äººï¼Œæ—¢ä¸æ˜¯æ­£èƒ½é‡ï¼Œä¹Ÿä¸æ˜¯è´Ÿèƒ½é‡ï¼Œåæ­£æ²¡æœ‰å…¥é€‰å·²å‡ºç‰ˆã€Šç»“å©šè®°ã€‹å’Œå³å°†å‡ºç‰ˆçš„ã€Šç§è±†å¾—ç“œé›†ã€‹ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/d1840ee6gy1hq6pvhwjp0j20xwax4e83.jpg%22">https://tvax1.sinaimg.cn/large/d1840ee6gy1hq6pvhwjp0j20xwax4e83.jpg&quot;</a>  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OguMWwSQj">æˆ‘å¦ˆç»™æˆ‘æ‰“äº†ä¸€ä»½æ··åˆæœè”¬æ±ï¼šèƒ¡èåœ è¥¿è“èŠ± æŸ æª¬ç„¶ååˆç…®ç†Ÿäº†ç»™æˆ‘[å•èº«ç‹—]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ogumwwsqj/">
    
    
    
    
    
      
    
    æˆ‘å¦ˆç»™æˆ‘æ‰“äº†ä¸€ä»½æ··åˆæœè”¬æ±ï¼š<!-- raw HTML omitted -->èƒ¡èåœ è¥¿è“èŠ± æŸ æª¬<!-- raw HTML omitted -->ç„¶ååˆç…®ç†Ÿäº†ç»™æˆ‘<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OgxwLmsv6">åŸæ¥ä¸Šå°ç”³æ˜¯å¯¹çš„ï¼Œä¸ä¸Šè¿2-2å…´è®¸éƒ½æ²¡äº†æ˜¯å§ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ogxwlmsv6/">
    
    
    
    
    
      
    
    åŸæ¥ä¸Šå°ç”³æ˜¯å¯¹çš„ï¼Œä¸ä¸Šè¿2-2å…´è®¸éƒ½æ²¡äº†æ˜¯å§ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgB18q9cj">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.05.29 10:59ã€Œå‘œå‘¼å‘¼ã€æœ€è¿‘ï¼Œå†…å¿ƒç»å¸¸ä¼šå‡ºç°è¯è¯­ã€‚å¥½é«˜å…´ã€œ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogb18q9cj/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgB1a9ky4">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.05.29 10:59ã€Œæ¬¸å˜¿å˜¿ã€æ—©ä¸Šå¥½ã€œæ€»æ„Ÿè§‰ä»Šå¤©æœ‰ç‚¹èµ·ä¸æ¥åºŠã€‚æœ€è¿‘å·¥ä½œå¾ˆç´§å‡‘ä½†æ˜¯ä»Šå¤©æ”¾æ™´äº†ï¼Œ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogb1a9ky4/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=2">https://m.weibo.cn/search?containerid=2</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgB1bCRt2">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.05.29 14:38ã€Œå¹³å’Œã€æˆ‘è®¤ä¸ºèƒ½å¤Ÿæ‚ é—²åœ°åº¦è¿‡æ‚ é—²çš„æ—¶é—´æ˜¯éå¸¸é‡è¦çš„ã€‚ä½†æ˜¯ï¼Œå¦‚æœå¿ƒä¸­è¿˜æœ‰ä»€...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogb1bcrt2/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D">https://m.weibo.cn/search?containerid=231522type%3D</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgB1eCnoA">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.ä¹ƒæœ¨å‚46 &amp;NOGI46ann X [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogb1ecnoa/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ä¹ƒæœ¨å‚46 &amp;NOGI46ann X &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1hq6tm0gyr2j31kw16o1">https://tvax1.sinaimg.cn/large/006z6nxLgy1hq6tm0gyr2j31kw16o1</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgB1nC1vH">å¥½çš„æ£’çƒå…¬ä¸»ğŸ«°ğŸ»â¤ï¸ - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.NOGI46annâ‘ ï¼ãŠ—ï¸SHOWUP NIGHTER ç‰¹åˆ«å˜‰å®¾ç°åœºå‡ºæ¼”ï¼¼6æœˆ13æ—¥ï¼ˆå‘¨å››ï¼‰ä¹…ä¿å²ç»ªé‡Œå°†ä½œä¸ºç‰¹åˆ«å˜‰...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogb1nc1vh/">
    
    
    
    
    
      
    
    å¥½çš„æ£’çƒå…¬ä¸»ğŸ«°ğŸ»â¤ï¸<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.NOGI46ann&lt;br &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgB1rc4TT">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#shiorigram# .#ä¹ƒæœ¨å‚46ANN##è¯¦æƒ…è¯·å¬å¬å¹¿æ’­##å¤§å®¶çš„è¦æ±‚å¾ˆä¸¥æ ¼##è¡£è¢–åˆæŠ˜èµ·æ¥äº†##å¤§å®¶éƒ½æ¸©æŸ”ä¸€ç‚¹å§# [å›¾ç‰‡][å›¾ç‰‡...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogb1rc4tt/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extparam=%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extparam=%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgzuUwkbq">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#shiorigram# .è™½ç„¶å–œæ¬¢è¯è¯­ï¼Œä½†å¶å°”ï¼Œåªæ˜¯å¶å°”ï¼Œæˆ‘ä¸ä¼šç›¸ä¿¡è¯è¯­ã€‚ä¸æ˜¯ã€é‚£æ—¶ï¼Œä½ æ˜æ˜æ˜¯è¿™ä¹ˆè¯´çš„ã€‚ã€ï¼Œè€Œæ˜¯æƒ³ç›¸ä¿¡...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogzuuwkbq/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgzuW1d7W">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.ä¹ƒæœ¨æ‹ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogzuw1d7w/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ä¹ƒæœ¨æ‹ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hq6rbmusrtj30hs0nq0xr.jpg%22">https://tvax4.sinaimg.cn/large/006z6nxLgy1hq6rbmusrtj30hs0nq0xr.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OgB4dDgFC">é€™å€‹äººè¶Šä¾†è¶Šå¥½çœ‹ï¼ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ogb4ddgfc/">
    
    
    
    
    
      
    
    é€™å€‹äººè¶Šä¾†è¶Šå¥½çœ‹ï¼ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OgB4Z8prx">çœ¾æ‰€å‘¨çŸ¥ï¼Œå‡ºé–€è¸é’é‡é¤è¦å¸¶é ­ç›”ï¼ˆX) [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ogb4z8prx/">
    
    
    
    
    
      
    
    çœ¾æ‰€å‘¨çŸ¥ï¼Œå‡ºé–€è¸é’é‡é¤è¦å¸¶é ­ç›”ï¼ˆX) <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgvbcjDGt">è¿™ä¸€æ¬¡æ—¥æœ¬å¥³å­å›´æ£‹è”èµ›ï¼Œè™½ç„¶åªæœ‰5ä¸ªé˜Ÿï¼Œä¸è¿‡æœ‰ä¸€ç‚¹å€¼å¾—è‚¯å®šçš„æ˜¯ï¼Œåœ¨æ–°é—»å‘å¸ƒä¼šä¹‹åä¸åˆ°1ä¸ªå°æ—¶ï¼Œ5æ”¯é˜Ÿä¼å°±åœ¨Xï¼ˆæ—§æ¨ç‰¹ï¼‰ä¸ŠæŠŠé˜Ÿä¼çš„ä¸“å±å¸å·éƒ½å¼€é€šäº†#å›´æ£‹#å›´æ£‹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogvbcjdgt/">
    
    
    
    
    
      
    
    è¿™ä¸€æ¬¡æ—¥æœ¬å¥³å­å›´æ£‹è”èµ›ï¼Œè™½ç„¶åªæœ‰5ä¸ªé˜Ÿï¼Œä¸è¿‡æœ‰ä¸€ç‚¹å€¼å¾—è‚¯å®šçš„æ˜¯ï¼Œåœ¨æ–°é—»å‘å¸ƒä¼šä¹‹åä¸åˆ°1ä¸ªå°æ—¶ï¼Œ5æ”¯é˜Ÿä¼å°±åœ¨Xï¼ˆæ—§æ¨ç‰¹ï¼‰ä¸ŠæŠŠé˜Ÿä¼çš„ä¸“å±å¸å·éƒ½å¼€é€šäº†<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png%22">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgzmyiaHo">å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šæœ€å¹´è½»å®šæ®µçºªå½•â€”â€”èµµæ²»å‹‹ã€Šæˆ‘çš„å±¥å†ä¹¦ã€‹ï¼ˆ7ï¼‰ã€‹ #å›´æ£‹# å›´æ£‹ æœ€å¹´è½»å®šæ®µçºªå½•â€”â€”èµµæ²»å‹‹ã€Šæˆ‘çš„å±¥å†ä¹¦ã€‹ï¼ˆ7ï¼‰ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogzmyiaho/">
    
    
    
    
    
      
    
    å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šæœ€å¹´è½»å®šæ®µçºªå½•â€”â€”èµµæ²»å‹‹ã€Šæˆ‘çš„å±¥å†ä¹¦ã€‹ï¼ˆ7ï¼‰ã€‹ <!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgA0CAMoj">ä¹…ä¿å²ç»ªé‡Œvia.ä¹ƒæœ¨å‚46 &amp;NOGI46ann X [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oga0camoj/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ä¹ƒæœ¨å‚46 &amp;NOGI46ann X <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z">https://tvax2.sinaimg.cn/large/006z</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgAsRdiOh">ä¹…ä¿å²ç»ªé‡Œvia.NOGI46annâ‘ ï¼ãŠ—ï¸SHOWUP NIGHTER ç‰¹åˆ«å˜‰å®¾ç°åœºå‡ºæ¼”ï¼¼6æœˆ13æ—¥ï¼ˆå‘¨å››ï¼‰ä¹…ä¿å²ç»ªé‡Œå°†ä½œä¸ºç‰¹åˆ«å˜‰å®¾å‡ºæ¼”åœ¨æ•…ä¹¡ãƒ»ä»™å°çš„ã€Œä¹å¤©Mobile Parkå®«åŸã€ä¸¾åŠçš„...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogasrdioh/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.NOGI46ann<!-- raw HTML omitted -->â‘ <!-- raw HTML omitted -->ï¼<!-- raw HTML omitted -->ãŠ—ï¸SHOWUP NIGHTER ç‰¹åˆ«å˜‰å®¾ç°åœºå‡ºæ¼”<!-- raw HTML omitted -->ï¼¼<!-- raw HTML omitted --><!-- raw HTML omitted -->6æœˆ13æ—¥ï¼ˆå‘¨å››ï¼‰ä¹…ä¿å²ç»ªé‡Œå°†ä½œä¸ºç‰¹åˆ«å˜‰å®¾å‡ºæ¼”åœ¨æ•…ä¹¡ãƒ»ä»™å°çš„ã€Œä¹å¤©Mobile &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgAxUtNiV">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# .#ä¹ƒæœ¨å‚46ANN##è¯¦æƒ…è¯·å¬å¬å¹¿æ’­##å¤§å®¶çš„è¦æ±‚å¾ˆä¸¥æ ¼##è¡£è¢–åˆæŠ˜èµ·æ¥äº†##å¤§å®¶éƒ½æ¸©æŸ”ä¸€ç‚¹å§# [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogaxutniv/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->.<!-- raw HTML omitted -->&lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgzGgwV88">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.05.29 10:59ã€Œå‘œå‘¼å‘¼ã€æœ€è¿‘ï¼Œå†…å¿ƒç»å¸¸ä¼šå‡ºç°è¯è¯­ã€‚å¥½é«˜å…´ã€œ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogzggwv88/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpage=1%22">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpage=1&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgzGmzgbe">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.05.29 10:59ã€Œæ¬¸å˜¿å˜¿ã€æ—©ä¸Šå¥½ã€œæ€»æ„Ÿè§‰ä»Šå¤©æœ‰ç‚¹èµ·ä¸æ¥åºŠã€‚æœ€è¿‘å·¥ä½œå¾ˆç´§å‡‘ä½†æ˜¯ä»Šå¤©æ”¾æ™´äº†ï¼Œæ„Ÿè§‰å¾ˆèˆ’æœå‘¢ã€‚æƒ³å»æ•£æ­¥ã€‚è¯è¯´èµ·æ¥...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogzgmzgbe/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%259">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgzLB2w3w">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.05.29 14:38ã€Œå¹³å’Œã€æˆ‘è®¤ä¸ºèƒ½å¤Ÿæ‚ é—²åœ°åº¦è¿‡æ‚ é—²çš„æ—¶é—´æ˜¯éå¸¸é‡è¦çš„ã€‚ä½†æ˜¯ï¼Œå¦‚æœå¿ƒä¸­è¿˜æœ‰ä»€ä¹ˆå›°æ‰°ï¼Œå°±ä¸å®¹æ˜“åšåˆ°ã€‚å¸Œæœ›æœ‰ä¸€å¤©...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogzlb2w3w/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Ogzuyf0EQ">ä¹…ä¿å²ç»ªé‡Œvia.ä¹ƒæœ¨æ‹ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogzuyf0eq/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ä¹ƒæœ¨æ‹ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hq6rbn8uncj30hs0">https://tvax4.sinaimg.cn/large/006z6nxLgy1hq6rbn8uncj30hs0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OgwZWbyVx">æŸ¯æ´#2024ä¹å±…ä¹æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›##èµ›äº‹æŠ¥é“# - è½¬å‘ @æ–°æµªæ£‹ç‰Œ:&amp;ensp;#2024ä¹å±…ä¹æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›# æ·±åœ³é¾™åé˜ŸæŸ¯æ´ä¸­ç›˜èƒœä¸Šæµ·èšç”³ä½“è‚²é˜Ÿæç»´æ¸…ï¼Œèµ›åå¤ç›˜ ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ogwzwbyvx/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/Ogx0wnkYi">æŸ¯æ´#2024ä¹å±…ä¹æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›##èµ›æœå‘å¸ƒ# 2024ä¹å±…ä¹æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›å¸¸è§„èµ›ç¬¬äºŒè½®ï¼ŒæŸ¯æ´ä¹æ®µæ‰§ç™½216æ‰‹ä¸­ç›˜èƒœæç»´æ¸…ä¹æ®µã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ogx0wnkyi/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/Ogx1w5BSp">æŸ¯æ´#2024ä¹å±…ä¹æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›##èµ›äº‹æŠ¥é“# - è½¬å‘ @å¤©æ¶¯æ£‹äºº:&amp;ensp;#2024ä¹å±…ä¹æ¯å›´ç”²è”èµ›# 2024å›´ç”²è”èµ›ç¬¬äºŒè½®ï¼Œæ·±åœ³é¾™åé˜Ÿå¯¹ä¸Šæµ·èšç”³ä½“è‚²é˜Ÿï¼ŒæŸ¯æ´ä¹æ®µå¯¹...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ogx1w5bsp/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%23202">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%23202</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/Ogxf6hYWf">æŸ¯æ´#2024ä¹å±…ä¹æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›# #èµ›æœå‘å¸ƒ# é™¶æ¬£ç„¶èƒœéŸ©ä¸€æ´²ï¼Œæœ´å»·æ¡“èƒœé»„æ˜å®‡ï¼Œæ—¶è¶Šè´Ÿç‹æ˜Ÿæ˜Šï¼ŒæŸ¯æ´èƒœæç»´æ¸…ï¼Œæ·±åœ³é¾™åé˜Ÿ3:1ä¸Šæµ·èšç”³ä½“è‚²é˜Ÿ[å½©è™¹å±] - è½¬å‘ @...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ogxf6hywf/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%2320">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%2320</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/266439161/answer/3468983526">ç‹è¯—ç¿”èµåŒäº†å›ç­”: å¦‚ä½•è¯„ä»·é¢œå®çš„ç§‘ç ”èƒ½åŠ›ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-266439161-answer-3468983526/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/648408795/answer/3513153521">ä¹Œé¸¦æ ¡å°‰èµåŒäº†å›ç­”: æ¯”äºšè¿ªDM5.0æŠ€æœ¯å‘å¸ƒï¼Œç™¾å…¬é‡Œæ²¹è€—åšåˆ°2.9Lï¼Œç»¼åˆç»­èˆªé‡Œç¨‹çªç ´2100KMï¼Œä¼šå¯¹è½¦å¸‚å¸¦æ¥å“ªäº›å½±å“ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-648408795-answer-3513153521/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/653342301/answer/3513908468">ä¹Œé¸¦æ ¡å°‰å›ç­”äº†é—®é¢˜: å¦‚ä½•è¯„ä»·ä¿„ç½—æ–¯Tï¼ˆSUï¼‰-72æµ·é¾Ÿå¦å…‹?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-653342301-answer-3513908468/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/657335522/answer/3512507381">ä¹Œé¸¦æ ¡å°‰èµåŒäº†å›ç­”: è‘£æ˜ç è¡¨ç¤ºã€Œ 35 å²æ²¡äººè˜ä½ å°±è‡ªå·±å»åˆ›ä¸šã€ï¼Œè¿˜ç›´è¨€æœ‰è´¡çŒ®æ‰èƒ½è°ˆæ”¶å…¥ï¼Œå¦‚ä½•çœ‹å¾…å¥¹çš„è¨€è®ºï¼Ÿåˆ›ä¸šå¯è¡Œå—ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-657335522-answer-3512507381/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://yufree.cn/en/2024/05/29/reactomics-analysis-for-ms-only-data/">Reactomics analysis for MS-only data</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/yufree-cn-en-2024-05-29-reactomics-analysis-for-ms-only-data/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700431801">é‡å­ä½å‘è¡¨äº†æ–‡ç« : èš‚èšæŠ€æœ¯æ—¥é¦–æ¬¡å¯¹å¤–å¼€æ”¾ï¼Œå„ç§å¤§æ¨¡å‹åº”ç”¨çœ‹èŠ±äº†</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700431801/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700474198">é‡å­ä½å‘è¡¨äº†æ–‡ç« : Ilyaå·¦è†€å³è‡‚è¢«Claudeå›¢é˜ŸæŒ–èµ°ï¼å¥¥ç‰¹æ›¼ç æ‰çš„è¶…çº§å¯¹é½ç®—åŠ›ï¼ŒAnthropicç»™äº†</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700474198/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700474621">é‡å­ä½å‘è¡¨äº†æ–‡ç« : Karpathyæ–°æ•™ç¨‹çˆ†ç«ï¼Œç½‘å‹æŠ¢ç€é€ä»–H100ï¼šä»å¤´å¤ç°GPT-2è®­ç»ƒ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700474621/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700480706">çŒ«å“¥çš„è§†ç•Œå‘è¡¨äº†æ–‡ç« : åŸåˆ›ï¼šå¯¹å°ç­–ç•¥å·²ç»æ˜¯æ˜ç‰Œï¼Œä¹Ÿæ˜¯æœ€é«˜æ˜çš„é˜³è°‹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700480706/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700536217">ä¹Œé¸¦æ ¡å°‰å‘è¡¨äº†æ–‡ç« : ä»â€œç›–ä¸­ç›–â€åˆ°â€œæ–°ç›–ä¸­ç›–â€ï¼Œæˆ‘ä»¬æ­£åœ¨è§è¯å¦å…‹çš„â€œé€€åŒ–å²â€ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700536217/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700550846">é‡å­ä½å‘è¡¨äº†æ–‡ç« : æåŒ»å­¦å½±åƒï¼Œä¸ºä»€ä¹ˆéƒ½é’çäºCPUï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700550846/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700552799">é‡å­ä½å‘è¡¨äº†æ–‡ç« : 3Dç”Ÿæˆç«æŠ€åœºæ¥äº†ï¼æ¯”æ‹¼360Â°ç¯ç»•è§†é¢‘ï¼Œæœ€å¼ºæ¨¡å‹ç”±ä½ pick</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700552799/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700556896">é‡å­ä½å‘è¡¨äº†æ–‡ç« : 16.9ä¸‡ä¸ªç”Ÿç‰©ç‰©ç§æ•°æ®ï¼Œè®©å¤§æ¨¡å‹ç†è§£ç”Ÿç‰©ä¸­å¿ƒæ³•åˆ™ï¼Œæ ¸é…¸å’Œè›‹ç™½è´¨å¯¹åº”å…³ç³»é¢„æµ‹å‡†ç¡®ç‡è¾¾0.85ï½œå·²å¼€æº</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700556896/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700566871">é‡å­ä½å‘è¡¨äº†æ–‡ç« : 3ä¸ªMITç‰©ç†åšå£«å†²åˆºAIåˆ¶è¯ç¬¬ä¸€è‚¡ï¼Œ9å¹´èèµ„53äº¿ä¼°å€¼143äº¿ï¼Œè¾‰ç‘å¼ºç”Ÿéƒ½æ˜¯å®¢æˆ·</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-29</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700566871/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38803093/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240528181652&amp;v=2.18.0.post9&#43;e462414">Conformational and Substitution Effects on the Donor and Reducing Strength of Tin(II) Porphyrinogens</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38803093-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240528181652-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Meso-octaalkylcalix[4]pyrrolates are a class of redox-active porphyrinogen ligands. They have been well established in d- and f-block chemistry for over three decades but have only recently been introduced as ligands for p-block elements. Here, we present a study on the influence of meso-substituents on the redox chemistry of calix[4]pyrrolato stannate(II) dianions [2R]2- (R = Me, Et). Expansion of the normal-mode structural decomposition (NSD) method, well known for porphyrin &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38803144/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240528181652&amp;v=2.18.0.post9&#43;e462414">Building and validating an artificial intelligence model to identify tracheobronchopathia osteochondroplastica by using bronchoscopic images</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38803144-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240528181652-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: We built an AI model that could differentiate TO from other multinodular airway diseases (mainly amyloidosis, tumors, and inflammation) by using bronchoscopic images. The model could help young physicians identify this rare airway &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38803222/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240528181652&amp;v=2.18.0.post9&#43;e462414">Full-length MSP1 is a major target of protective immunity after controlled human malaria infection</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38803222-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240528181652-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The merozoite surface protein 1 (MSP1) is the most abundant protein on the surface of the invasive merozoite stages of Plasmodium falciparum and has long been considered a key target of protective immunity. We used samples from a single controlled human malaria challenge study to test whether the full-length version of MSP1 (MSP1(FL)) induced antibodies that mediated Fc-IgG functional activity in five independent assays. We found that anti-MSP1(FL) antibodies induced complement fixation via &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38803239/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240528181652&amp;v=2.18.0.post9&#43;e462414">Stroke outcomes following durable left ventricular assist device implant in patients bridged with micro-axial flow pump: Insights from a large registry</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38803239-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240528181652-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Among patients undergoing d-LVAD implantation following mAFP support, tMCS characteristics do not impact ischemic stroke occurrence, while several factors are associated with hemorrhagic stroke suggesting a proactive treatment target to reduce this &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38803922/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240528181652&amp;v=2.18.0.post9&#43;e462414">Decoding common genetic alterations between Barrett&#39;s esophagus and esophageal adenocarcinoma: A bioinformatics analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38803922-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240528181652-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The present study provides novel potential candidate genes that may be involved in the molecular association between Esophageal adenocarcinoma and Barrett&rsquo;s Esophagus, resulting in developing the diagnostic tools and therapeutic targets to prevent progression of BE to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804018/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240528181652&amp;v=2.18.0.post9&#43;e462414">The role of the nucleus for cell mechanics: an elastic phase field approach</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804018-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240528181652-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The nucleus of eukaryotic cells typically makes up around 30% of the cell volume and has significantly different mechanics, which can make it effectively up to ten times stiffer than the surrounding cytoplasm. Therefore it is an important element for cell mechanics, but a quantitative understanding of its mechanical role during whole cell dynamics is largely missing. Here we demonstrate that elastic phase fields can be used to describe dynamical cell processes in adhesive or &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804170/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240528181652&amp;v=2.18.0.post9&#43;e462414">Jet-injection assisted photodynamic therapy for superficial and nodular basal cell carcinoma: A pilot study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804170-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240528181652-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Jet injection of ALA for PDT treatment of nodular low-risk BCC is tolerable and feasible and may represent a novel modality to improve &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804172/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240528181652&amp;v=2.18.0.post9&#43;e462414">Development of a single-domain antibody to target a G-quadruplex located on the hepatitis B virus covalently closed circular DNA genome</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804172-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240528181652-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    To achieve a virological cure for hepatitis B virus (HBV), innovative strategies are required to target the covalently closed circular DNA (cccDNA) genome. Guanine-quadruplexes (G4s) are a secondary structure that can be adopted by DNA and play a significant role in regulating viral replication, transcription, and translation. Antibody-based probes and small molecules have been developed to study the role of G4s in the context of the human genome, but none have been specifically made to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804405/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&amp;fc=20220814223158&amp;ff=20240528181551&amp;v=2.18.0.post9&#43;e462414">Clinical Case of Mild Tatton-Brown-Rahman Syndrome Caused by a Nonsense Variant in &lt;em&gt;DNMT3A&lt;/em&gt; Gene</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804405-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1byxlwg-5hn0-qdlgzypdfla2uwghgngzgereuo1rjn2aoaqxp-fc-20220814223158-ff-20240528181551-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Tatton-Brown-Rahman syndrome is a rare autosomal dominant hereditary disease caused by pathogenic variants in the DNMT3A gene, which is an important participant in epigenetic regulation, especially during embryonic development, and is highly expressed in all tissues. The main features of the syndrome are high growth, macrocephaly, intellectual disability, and facial dysmorphic features. We present a clinical case of Tatton-Brown-Rahman syndrome in a ten-year-old boy with macrocephaly &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804405/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&amp;fc=20220814223158&amp;ff=20240529181055&amp;v=2.18.0.post9&#43;e462414">Clinical Case of Mild Tatton-Brown-Rahman Syndrome Caused by a Nonsense Variant in &lt;em&gt;DNMT3A&lt;/em&gt; Gene</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804405-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1byxlwg-5hn0-qdlgzypdfla2uwghgngzgereuo1rjn2aoaqxp-fc-20220814223158-ff-20240529181055-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Tatton-Brown-Rahman syndrome is a rare autosomal dominant hereditary disease caused by pathogenic variants in the DNMT3A gene, which is an important participant in epigenetic regulation, especially during embryonic development, and is highly expressed in all tissues. The main features of the syndrome are high growth, macrocephaly, intellectual disability, and facial dysmorphic features. We present a clinical case of Tatton-Brown-Rahman syndrome in a ten-year-old boy with macrocephaly &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804507/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240528181550&amp;v=2.18.0.post9&#43;e462414">Toward a Tobacco-free Generation - A Birth Date-Based Phaseout Approach</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804507-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240528181550-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804507/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240529181055&amp;v=2.18.0.post9&#43;e462414">Toward a Tobacco-free Generation - A Birth Date-Based Phaseout Approach</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804507-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240529181055-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804510/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240528181550&amp;v=2.18.0.post9&#43;e462414">Red-Cell Rosette Formation in Malaria</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804510-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240528181550-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804510/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240529181055&amp;v=2.18.0.post9&#43;e462414">Red-Cell Rosette Formation in Malaria</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804510-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240529181055-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804512/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240528181652&amp;v=2.18.0.post9&#43;e462414">Autoantibodies Targeting Nephrin in Podocytopathies</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804512-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240528181652-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In this study, circulating antinephrin autoantibodies were common in patients with minimal change disease or idiopathic nephrotic syndrome and appeared to be markers of disease activity. Their binding at the slit diaphragm induced podocyte dysfunction and nephrotic syndrome, which highlights their pathophysiological significance. (Funded by Deutsche Forschungsgemeinschaft and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804512/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240528181550&amp;v=2.18.0.post9&#43;e462414">Autoantibodies Targeting Nephrin in Podocytopathies</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804512-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240528181550-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In this study, circulating antinephrin autoantibodies were common in patients with minimal change disease or idiopathic nephrotic syndrome and appeared to be markers of disease activity. Their binding at the slit diaphragm induced podocyte dysfunction and nephrotic syndrome, which highlights their pathophysiological significance. (Funded by Deutsche Forschungsgemeinschaft and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804512/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240529181055&amp;v=2.18.0.post9&#43;e462414">Autoantibodies Targeting Nephrin in Podocytopathies</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804512-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240529181055-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In this study, circulating antinephrin autoantibodies were common in patients with minimal change disease or idiopathic nephrotic syndrome and appeared to be markers of disease activity. Their binding at the slit diaphragm induced podocyte dysfunction and nephrotic syndrome, which highlights their pathophysiological significance. (Funded by Deutsche Forschungsgemeinschaft and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804514/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240528181550&amp;v=2.18.0.post9&#43;e462414">A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804514-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240528181550-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Felzartamab had acceptable safety and side-effect profiles in patients with antibody-mediated rejection. (Funded by MorphoSys and Human Immunology Biosciences; ClinicalTrials.gov number, NCT05021484; and EUDRACT number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804514/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240529181055&amp;v=2.18.0.post9&#43;e462414">A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804514-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240529181055-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Felzartamab had acceptable safety and side-effect profiles in patients with antibody-mediated rejection. (Funded by MorphoSys and Human Immunology Biosciences; ClinicalTrials.gov number, NCT05021484; and EUDRACT number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804517/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240528181550&amp;v=2.18.0.post9&#43;e462414">Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804517-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240528181550-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In this randomized, controlled trial involving participants with mixed hyperlipidemia, plozasiran, as compared with placebo, significantly reduced triglyceride levels at 24 weeks. A clinical outcomes trial is warranted. (Funded by Arrowhead Pharmaceuticals; MUIR ClinicalTrials.gov number &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804517/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240529181055&amp;v=2.18.0.post9&#43;e462414">Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804517-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240529181055-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In this randomized, controlled trial involving participants with mixed hyperlipidemia, plozasiran, as compared with placebo, significantly reduced triglyceride levels at 24 weeks. A clinical outcomes trial is warranted. (Funded by Arrowhead Pharmaceuticals; MUIR ClinicalTrials.gov number &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804518/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240528181550&amp;v=2.18.0.post9&#43;e462414">Snapshots</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804518-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240528181550-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804518/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240529181055&amp;v=2.18.0.post9&#43;e462414">Snapshots</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804518-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240529181055-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804595/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240528181652&amp;v=2.18.0.post9&#43;e462414">In Vivo Polymer Mechanochemistry with Polynucleotides</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804595-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240528181652-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Polymer mechanochemistry utilizes mechanical force to activate latent functionalities in macromolecules and widely relies on ultrasonication techniques. Fundamental constraints of frequency and power intensity have prohibited the application of the polymer mechanochemistry principles in a biomedical context up to now, although medical ultrasound is a clinically established modality. Here, a universal polynucleotide framework is presented that allows the binding and release of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804632/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240528181652&amp;v=2.18.0.post9&#43;e462414">Development of a Zebrafish Embryo-Based Test System for Thyroid Hormone System Disruption: 3Rs in Ecotoxicological Research</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804632-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240528181652-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    There is increasing concern regarding pollutants disrupting the vertebrate thyroid hormone (TH) system, which is crucial for development. Thus, identification of TH system-disrupting chemicals (THSDCs) is an important requirement in the Organisation for Economic Co-operation and Development (OECD) testing framework. The current OECD approach uses different model organisms for different endocrine modalities, leading to a high number of animal tests. Alternative models compatible with the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38804733/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240528181652&amp;v=2.18.0.post9&#43;e462414">Aggregation of N-Heteropolycyclic Aromatic Molecules: The Acridine Dimer and Trimer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38804733-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240528181652-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Polycyclic aromatic hydrocarbons and their nitrogen-substituted analogues are of great interest for various applications in organic electronics. The performance of such devices is determined not only by the properties of the single molecules, but also by the structure of their aggregates, which often form via self-aggregation. Gaining insight into such aggregation processes is a challenging task, but crucial for a fine-tuning of the materials properties. In this work, an efficient approach &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38805053/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240528181652&amp;v=2.18.0.post9&#43;e462414">Non-motor symptoms in patients with amyotrophic lateral sclerosis: current state and future directions</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38805053-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240528181652-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive degeneration of both upper and lower motor neurons. A defining histopathological feature in approximately 97% of all ALS cases is the accumulation of phosphorylated trans-activation response (TAR) DNA-binding protein 43 protein (pTDP-43) aggregates in the cytoplasm of neurons and glial cells within the central nervous system. Traditionally, it was believed that the accumulation of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38805637/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240529181009&amp;v=2.18.0.post9&#43;e462414">CD20-bispecific antibodies improve response to CD19-CAR T-cells in lymphoma in-vitro and CLL in-vivo models</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38805637-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240529181009-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Anti-CD19 chimeric antigen receptor T-cells (CD19-CAR) represent an effective treatment for relapsed/refractory B-cell malignancies but incomplete responses often result in early disease progression. We here assessed potential benefits of co-administering CD20-targeting bispecific antibodies (CD20-BsAb) with CD19-CAR, aiming to enhance immunotherapeutic efficacy. Addition of CD20-BsAb to co-cultures of CD19-CAR and primary samples of B-cell malignancies, comprising malignant B- and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38805638/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240529181009&amp;v=2.18.0.post9&#43;e462414">Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38805638-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240529181009-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    The introduction of all-trans retinoic acid (ATRA) combined with anthracyclines has significantly improved the outcomes for patients with acute promyelocytic leukemia (APL), and this strategy remains the standard of care in countries where arsenic trioxide is not affordable. However, data from national registries and real-world databases indicate that low- and middle-income countries (LMIC) still face disappointing results, mainly due to high induction mortality and suboptimal management &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38805639/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240529181009&amp;v=2.18.0.post9&#43;e462414">Adaptation to ex vivo culture reduces human hematopoietic stem cell activity independently of cell cycle</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38805639-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240529181009-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Loss of long-term hematopoietic stem cell (LT-HSC) function ex vivo hampers the success of clinical protocols reliant on culture. However, the kinetics and mechanisms by which this occurs remain incompletely characterized. Here, through time-resolved scRNA-Seq, matched in vivo functional analysis and the use of a reversible in vitro system of early G1 arrest, we define the sequence of transcriptional and functional events occurring during the first ex vivo division of human LT-HSCs. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38806058/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">AspSnFR: A genetically encoded biosensor for real-time monitoring of aspartate in live cells</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38806058-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Aspartate is crucial for nucleotide synthesis, ammonia detoxification, and maintaining redox balance via the malate-aspartate-shuttle (MAS). To disentangle these multiple roles of aspartate metabolism, tools are required that measure aspartate concentrations in real time and in live cells. We introduce AspSnFR, a genetically encoded green fluorescent biosensor for intracellular aspartate, engineered through displaying and screening biosensor libraries on mammalian cells. In live cells, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38806430/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">Design of the multicentre randomised controlled BENTO trial to demonstrate patient-relevant benefit of bronchoscopic lung volume reduction using thermal vapour ablation in the German healthcare system for patients with upper lobe emphysema: a study protocol</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38806430-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: Application of vapour ablation as a novel approach to lung volume reduction has positive effects in patients with severe emphysema. The BENTO study is a randomised, controlled, open, multicentre trial, to assess the effects of bronchoscopic thermal vapour ablation (BTVA) in the German healthcare &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38806504/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38806504-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The chemokine CXCL12 promotes glioblastoma (GBM) recurrence after radiotherapy (RT) by facilitating vasculogenesis. Here we report outcomes of the dose-escalation part of GLORIA (NCT04121455), a phase I/II trial combining RT and the CXCL12-neutralizing aptamer olaptesed pegol (NOX-A12; 200/400/600 mg per week) in patients with incompletely resected, newly-diagnosed GBM lacking MGMT methylation. The primary endpoint was safety, secondary endpoints included maximum tolerable dose &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38806626/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">Unmet healthcare needs, access to services and experiences with health providers among persons with spinal cord injury in Australia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38806626-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Unmet healthcare needs were reported in the context of high healthcare use and large proportions of secondary conditions in a cohort with long-term SCI. Improved health access for people with SCI include better primary-secondary care collaboration is &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38806674/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">Chronic spindle assembly checkpoint activation causes myelosuppression and gastrointestinal atrophy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38806674-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Interference with microtubule dynamics in mitosis activates the spindle assembly checkpoint (SAC) to prevent chromosome segregation errors. The SAC induces mitotic arrest by inhibiting the anaphase-promoting complex (APC) via the mitotic checkpoint complex (MCC). The MCC component MAD2 neutralizes the critical APC cofactor, CDC20, preventing exit from mitosis. Extended mitotic arrest can promote mitochondrial apoptosis and caspase activation. However, the impact of mitotic cell death on &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38806706/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">Bacillamide D produced by Bacillus cereus from the mouse intestinal bacterial collection (miBC) is a potent cytotoxin in vitro</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38806706-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The gut microbiota influences human health and the development of chronic diseases. However, our understanding of potentially protective or harmful microbe-host interactions at the molecular level is still in its infancy. To gain further insights into the hidden gut metabolome and its impact, we identified a cryptic non-ribosomal peptide BGC in the genome of Bacillus cereus DSM 28590 from the mouse intestine ( <a href="http://www.dsmz.de/miBC">www.dsmz.de/miBC</a> ), which was predicted to encode a thiazol(in)e substructure. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38806714/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">Cell-type-specific consequences of mosaic structural variants in hematopoietic stem and progenitor cells</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38806714-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The functional impact and cellular context of mosaic structural variants (mSVs) in normal tissues is understudied. Utilizing Strand-seq, we sequenced 1,133 single-cell genomes from 19 human donors of increasing age, and discovered the heterogeneous mSV landscapes of hematopoietic stem and progenitor cells. While mSVs are continuously acquired throughout life, expanded subclones in our cohort are confined to individuals &gt;60. Cells already harboring mSVs are more likely to acquire &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38806718/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">Controversy on health-based guidance values for bisphenol A-the need of criteria for studies that serve as a basis for risk assessment</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38806718-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Since 2006, the responsible regulatory bodies have proposed five health-based guidance values (HBGV) for bisphenol A (BPA) that differ by a factor of 250,000. This range of HBGVs covers a considerable part of the range from highly toxic to relatively non-toxic substances. As such heterogeneity of regulatory opinions is a challenge not only for scientific risk assessment but also for all stakeholders, the Senate Commission on Food Safety (SKLM) of the German Research Foundation (DFG) analyzed &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38806751/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">Do no harm!</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38806751-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38807165/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">Interaction-focused music therapy with cancer-affected children and their significant others: a randomized controlled feasibility study with subsequent intervention (INMUT)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38807165-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Paediatric oncology/haematology patients and their families are confronted with a life-threatening situation for which music therapy can be a cross-linguistic field of action. The creative act of making music together offers the possibility to strengthen competences and make conflicts tangible. Besides its complementing of evidence-based biomedical care, there is little research on the feasibility and efficacy of interactive music therapy including the diagnosed child and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38807179/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">Healthy lifestyle change and all-cause and cancer mortality in the European Prospective Investigation into Cancer and Nutrition cohort</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38807179-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Making healthier lifestyle changes during adulthood was inversely associated with all-cause and cancer mortality and delayed risk of death. Conversely, making unhealthier lifestyle changes was positively associated with mortality and an accelerated risk of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38807208/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240529181135&amp;v=2.18.0.post9&#43;e462414">Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38807208-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240529181135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: This biochemical and immunological study showcases the potential of an effective combination therapy with two monoclonal anti-gB IgGs for the treatment of HSV-1/2 induced disease &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OgrFkcggS">æˆ‘è§‰å¾—2017-2018å¹´æ˜¯ç¾å›½popçš„é›†å¤§æˆå¼ç¹ç››çš„ä¸¤å¹´ï¼Œæ¶Œç°äº†æå¤§é‡çƒ­é—¨æ­Œæ›²ï¼Œéƒ½æ˜¯YouTubeé«˜ç‚¹å‡»æ­Œæ›²å’ŒBillboardé«˜è¯„æ­Œæ›²ï¼Œä¹Ÿæ˜¯6-7å¹´åæˆ‘ä¾ç„¶æ— é™å¾ªç¯çš„ï¼Œæœ‰ï¼šDespa...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ogrfkcggs/">
    
    
    
    
    
      
    
    æˆ‘è§‰å¾—2017-2018å¹´æ˜¯ç¾å›½popçš„é›†å¤§æˆå¼ç¹ç››çš„ä¸¤å¹´ï¼Œæ¶Œç°äº†æå¤§é‡çƒ­é—¨æ­Œæ›²ï¼Œéƒ½æ˜¯YouTubeé«˜ç‚¹å‡»æ­Œæ›²å’ŒBillboardé«˜è¯„æ­Œæ›²ï¼Œä¹Ÿæ˜¯6-7å¹´åæˆ‘ä¾ç„¶æ— é™å¾ªç¯çš„ï¼Œæœ‰ï¼šDespacito, Something Just Like This, Closer, Believer, Say You Wonâ€™t Let Go, Attention, Thereâ€™s Nothing Holdinâ€™ Me Back, I Donâ€™t Wanna Live Forever, Slow Hands, Love on the Brain, I Feel It Coming, Paris, Side to Side, Rockabye, Canâ€™t Stop the Feeling!, Eastside, Perfect, Meant to Be, Rockstar, The Middle, Girls Like You, Thunder, Bad at Love, I Like Me Better, Youngblood, Whatever It Takes, Too Good at Goodbyesã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹‹åpopå°±è¿›å…¥äº†ä¸€æ®µæ¶ˆæ²‰æ—¶é—´ã€‚ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/OgmKtCAYC">ä½ ä»¬é‡åº†çš„çŒ«éƒ½è¿™ä¹ˆéšä¾¿å—â€¦â€¦èµ°ç€èµ°ç€ï¼Œè¿™ä½å’£å½“ä¸€å£°èººåœ¨è„šå‰ï¼Œéœ²å‡ºè‚šçš®ï¼Œå›å¤´å¨ä¸¥åœ°çœ‹ç€æˆ‘ã€‚ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-ogmktcayc/">
    
    
    
    
    
      
    
    ä½ ä»¬é‡åº†çš„çŒ«éƒ½è¿™ä¹ˆéšä¾¿å—â€¦â€¦èµ°ç€èµ°ç€ï¼Œè¿™ä½å’£å½“ä¸€å£°èººåœ¨è„šå‰ï¼Œéœ²å‡ºè‚šçš®ï¼Œå›å¤´å¨ä¸¥åœ°çœ‹ç€æˆ‘ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1655755343/Ogl9HfyGR">ä»Šå¹´æ˜¥å¤©èº«ä½“ä¸€ç›´ä¸æ€ä¹ˆå¥½ï¼Œåªå‚åŠ äº†ä¸€åœºç­”è¾©ã€‚æ˜¨æ™šæ˜æ˜æ²‰æ²‰åˆæ„Ÿå†’ä½çƒ§ï¼Œæƒ³åˆ°å¾ˆå¤šï¼Œå…³äºè¿‡å»å’Œæœªæ¥ã€‚ç¥ç¦å¤§å®¶æ¯•ä¸šï¼å‰ç¨‹é”¦ç»£[å¿ƒ]6.2MFAåäº”å‘¨å¹´æ´»åŠ¨è§[å¤ªé˜³] - ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1655755343-ogl9hfygr/">
    
    
    
    
    
      
    
    ä»Šå¹´æ˜¥å¤©èº«ä½“ä¸€ç›´ä¸æ€ä¹ˆå¥½ï¼Œåªå‚åŠ äº†ä¸€åœºç­”è¾©ã€‚æ˜¨æ™šæ˜æ˜æ²‰æ²‰åˆæ„Ÿå†’ä½çƒ§ï¼Œæƒ³åˆ°å¾ˆå¤šï¼Œå…³äºè¿‡å»å’Œæœªæ¥ã€‚ç¥ç¦å¤§å®¶æ¯•ä¸šï¼å‰ç¨‹é”¦ç»£<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->6.2MFAåäº”å‘¨å¹´æ´»åŠ¨è§<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å¤æ—¦åˆ›æ„å†™ä½œ&lt;/a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1655755343/OgoHcAht6">#æƒ…å…³è¥¿æ¸¸#ä»Šå¤©åŒå­¦æ’äº†ä¸ªå¾ˆå‰å®³çš„å°å“ã€‚æ”¹äº†â€œå­æ¯æ²³â€ï¼Œå®Œæˆäº†è™šæ‹Ÿå™è¿°ï¼Œè®©å”åƒ§æ€€å­•ï¼Œç”Ÿä¸‹äº†å­©å­ï¼Œä¸å¥³å›½å›½ç‹äº‰æŠšå…»æƒã€‚å¥³å›½å›½ç‹è®¤ä¸ºï¼Œå­æ¯æ²³çš„å­©å­æ˜¯æ¥è‡ªå…¬å…±...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1655755343-ogohcaht6/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted -->#æƒ…å…³è¥¿æ¸¸#<!-- raw HTML omitted --><!-- raw HTML omitted -->ä»Šå¤©åŒå­¦æ’äº†ä¸ªå¾ˆå‰å®³çš„å°å“ã€‚æ”¹äº†â€œå­æ¯æ²³â€ï¼Œå®Œæˆäº†è™šæ‹Ÿå™è¿°ï¼Œè®©å”åƒ§æ€€å­•ï¼Œç”Ÿä¸‹äº†å­©å­ï¼Œä¸å¥³å›½å›½ç‹äº‰æŠšå…»æƒã€‚å¥³å›½å›½ç‹è®¤ä¸ºï¼Œå­æ¯æ²³çš„å­©å­æ˜¯æ¥è‡ªå…¬å…±åª’ä»‹ï¼Œå”åƒ§è®¤ä¸ºè‡ªå·±å®Œæˆäº†ç”Ÿè‚²ï¼Œå­©å­æ˜¯è‡ªå·±çš„ã€‚ä¼¦ç†ä¸Šå¤ªå‰æ²¿äº†ï¼Œç¡®å®æ˜¯ä¸€éš¾<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒæµçš„åŒå­¦å†™çš„å‰§æœ¬ğŸ‘ &lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgqBjkADA">ç»ƒä¸€ä¸ªæ™ºæ…§ç”Ÿç‰©ï¼Œç»ƒåˆ°ç°åœ¨èƒ½è·Ÿä½ æœ‰é—®æœ‰ç­”äº†ï¼Œè¿˜èƒ½æœ‰æ¯”è¿™æ›´å¥½ç©çš„ï¼Ÿ//@æ€¡é¦¨_jes:æœ€åä¸¤æ¬¾å“ªä¸ªæ›´æ°”äººï¼Ÿ[æŒ–é¼»] - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»å› ä¸ºè€çœ‹åˆ°è¯„è®ºåŒº...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogqbjkada/">
    
    
    
    
    
      
    
    ç»ƒä¸€ä¸ªæ™ºæ…§ç”Ÿç‰©ï¼Œç»ƒåˆ°ç°åœ¨èƒ½è·Ÿä½ æœ‰é—®æœ‰ç­”äº†ï¼Œè¿˜èƒ½æœ‰æ¯”è¿™æ›´å¥½ç©çš„ï¼Ÿ//<!-- raw HTML omitted -->@æ€¡é¦¨_jes<!-- raw HTML omitted -->:æœ€åä¸¤æ¬¾å“ªä¸ªæ›´æ°”äººï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»å› ä¸ºè€çœ‹åˆ°è¯„è®ºåŒºè¯´â€œä½ è¿˜ç©è¿™ä¸ª<!-- raw HTML omitted -->&lt;img alt=&quot;[è´¹è§£]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/default/d">https://h5.sinaimg.cn/m/emoticon/icon/default/d</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgqCIFIdJ">ğŸ”»[doge]#ä»¥è‰²åˆ—æ‹Ÿè®¤å®šè”åˆå›½æœºæ„ä¸ºææ€–ç»„ç»‡#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogqcifidj/">
    
    
    
    
    
      
    
    ğŸ”»<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%BB%A5%E8%89%B2%E5%88%97%E6%8B%9F%E8%AE%A4%E5%AE%9A%E8%81%94%E5%90%88%E5%9B%BD%E6%9C%BA%E6%9E%84%E4%B8%BA%E6%81%90%E6%80%96%E7%BB%84%E7%BB%87%23&amp;amp;extparam=%23%E4%BB%A5%E8%89%B2%E5%88%97%E6%8B%9F%E8%AE%A4%E5%AE%9A%E8%81%94%E5%90%88%E5%9B%BD%E6%9C%BA%E6%9E%84%E4%B8%BA%E6%81%90%E6%80%96%E7%BB%84%E7%BB%87%23%22">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%BB%A5%E8%89%B2%E5%88%97%E6%8B%9F%E8%AE%A4%E5%AE%9A%E8%81%94%E5%90%88%E5%9B%BD%E6%9C%BA%E6%9E%84%E4%B8%BA%E6%81%90%E6%80%96%E7%BB%84%E7%BB%87%23&amp;amp;extparam=%23%E4%BB%A5%E8%89%B2%E5%88%97%E6%8B%9F%E8%AE%A4%E5%AE%9A%E8%81%94%E5%90%88%E5%9B%BD%E6%9C%BA%E6%9E%84%E4%B8%BA%E6%81%90%E6%80%96%E7%BB%84%E7%BB%87%23&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgqIX02Iq">ğŸ”»ç‰¢å¡ä»Šå¹´å¯èƒ½è¯¥å°å‡åˆäº†ã€‚#ä»¥è‰²åˆ—æ‹Ÿè®¤å®šè”åˆå›½æœºæ„ä¸ºææ€–ç»„ç»‡# [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogqix02iq/">
    
    
    
    
    
      
    
    ğŸ”»ç‰¢å¡ä»Šå¹´å¯èƒ½è¯¥å°å‡åˆäº†ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ä»¥è‰²åˆ—æ‹Ÿè®¤å®šè”åˆå›½æœºæ„ä¸ºææ€–ç»„ç»‡#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/639b1bfbly1hq5ol37x2mj20lo0egjyc.jpg%22">https://tvax3.sinaimg.cn/large/639b1bfbly1hq5ol37x2mj20lo0egjyc.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgqLY2OiQ">ğŸ”»å¤ºå† åçš„æ›¼è”çƒè¿·ã€‚ğŸ”»ä½†æ˜¯æ— æ‰€è°“ï¼Œæœ‰å† å»ã€‚ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogqly2oiq/">
    
    
    
    
    
      
    
    ğŸ”»å¤ºå† åçš„æ›¼è”çƒè¿·ã€‚<!-- raw HTML omitted -->ğŸ”»ä½†æ˜¯æ— æ‰€è°“ï¼Œæœ‰å† å»ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/639b1">https://tvax3.sinaimg.cn/large/639b1</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgqNoFnFp">ğŸ”»å”±æ­Œå•Šï¼Œå”±å•Šã€‚ åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogqnofnfp/">
    
    
    
    
    
      
    
    ğŸ”»å”±æ­Œå•Šï¼Œå”±å•Šã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/epYbWWwSlx08fdxztEIE010412003Svk0E010.mp4?label">https://f.video.weibocdn.com/o0/epYbWWwSlx08fdxztEIE010412003Svk0E010.mp4?label</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgqRxCkRI">æ‹¿äº†è¶³æ€»æ¯åå½»å¤œåº†ç¥ï¼Œå®¿é†‰åˆšé†’ï¼Œä¸æƒ³è¯´è¯ã€‚//@_éªéª¥:æˆ‘é­”å¤§å“¥ä¸ºå•¥ä¸å”±[äºŒå“ˆ] - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»å”±æ­Œå•Šï¼Œå”±å•Šã€‚ åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogqrxckri/">
    
    
    
    
    
      
    
    æ‹¿äº†è¶³æ€»æ¯åå½»å¤œåº†ç¥ï¼Œå®¿é†‰åˆšé†’ï¼Œä¸æƒ³è¯´è¯ã€‚//<!-- raw HTML omitted -->@_éªéª¥<!-- raw HTML omitted -->:æˆ‘é­”å¤§å“¥ä¸ºå•¥ä¸å”±<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»å”±æ­Œå•Šï¼Œå”±å•Šã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_smal">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_smal</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgqUj0DhK">ğŸ”»æ™šå®‰ã€‚ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogquj0dhk/">
    
    
    
    
    
      
    
    ğŸ”»æ™šå®‰ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgqWGpguY">ï¼Ÿ//@Dekafire:[æ˜¥æ¸¸å®¶æ—]æœ€è¿‘åœ¨æºœè¿™ä¸ªï¼Œå¡å¤§ä½Ã—åŸƒå°”ä¸¹ è¯„è®ºé…å›¾ - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»ç‰¢å¡ä»Šå¹´å¯èƒ½è¯¥å°å‡åˆäº†ã€‚#ä»¥è‰²åˆ—æ‹Ÿè®¤å®šè”åˆå›½æœºæ„ä¸ºææ€–ç»„...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogqwgpguy/">
    
    
    
    
    
      
    
    ï¼Ÿ//<!-- raw HTML omitted -->@Dekafire<!-- raw HTML omitted -->:<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æœ€è¿‘åœ¨æºœè¿™ä¸ªï¼Œå¡å¤§ä½Ã—åŸƒå°”ä¸¹ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgqyDojmx">é­”å…½ä¸–ç•Œä¹‹å‰æ›¾ç»ç©EverQuestï¼Œåæ¥è¿˜ç©FF14ï¼Œéƒ½Aäº†ã€‚ æŸ¥çœ‹å›¾ç‰‡ - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»å› ä¸ºè€çœ‹åˆ°è¯„è®ºåŒºè¯´â€œä½ è¿˜ç©è¿™ä¸ª[è´¹è§£]â€ï¼Œè¯´ä¸€ä¸‹æˆ‘ç©ä¸”ç›®å‰...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogqydojmx/">
    
    
    
    
    
      
    
    é­”å…½ä¸–ç•Œä¹‹å‰æ›¾ç»ç©EverQuestï¼Œåæ¥è¿˜ç©FF14ï¼Œéƒ½Aäº†ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¥çœ‹å›¾ç‰‡<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»å› ä¸ºè€çœ‹åˆ°è¯„è®ºåŒºè¯´â€œä½ è¿˜ç©è¿™ä¸ª<!-- raw HTML omitted -->&lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgqYrd9j5">ä»Šå¹´æˆ‘ä¸»ä¸šçš„æŸä¸ªå›½äº§æ›¿ä»£å“ç±»åœ¨å¾ˆç»†åˆ†çš„é¢†åŸŸåšåˆ°å…¨å›½top5äº†[doge]//@æ¹–å¿ƒé’“é›ª:åŒ…å§è¿™å¼ºåº¦è¿˜æœ‰æ—¶é—´ç©å•Š - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»å› ä¸ºè€çœ‹åˆ°è¯„è®ºåŒºè¯´â€œ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogqyrd9j5/">
    
    
    
    
    
      
    
    ä»Šå¹´æˆ‘ä¸»ä¸šçš„æŸä¸ªå›½äº§æ›¿ä»£å“ç±»åœ¨å¾ˆç»†åˆ†çš„é¢†åŸŸåšåˆ°å…¨å›½top5äº†<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@æ¹–å¿ƒé’“é›ª<!-- raw HTML omitted -->:åŒ…å§è¿™å¼ºåº¦è¿˜æœ‰æ—¶é—´ç©å•Š<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»å› ä¸ºè€çœ‹åˆ°è¯„è®ºåŒºè¯´â€œä½ è¿˜ç©è¿™ä¸ª<!-- raw HTML omitted -->&lt;img alt=&quot;[è´¹è§£]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/de">https://h5.sinaimg.cn/m/emoticon/icon/de</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Ogl2Nfswm">é‚“å…¬çš„å¾ˆå¤šä¸»å¼ ï¼Œæ°‘é—´å¹¶ä¸çŸ¥é“ã€‚æ˜¯æ‰¹é‚“åå‡»å³å€¾ç¿»æ¡ˆé£æŠŠè¿™äº›ä¸»å¼ æ˜­å‘Šå¤©ä¸‹ï¼Œè®©å¹¿å¤§äººæ°‘çŸ¥é“äº†é‚“å…¬çš„ä¼Ÿå¤§ã€‚æˆ‘é‚£æ—¶åœ¨å†œæ‘æ’é˜Ÿ ï¼Œè®¤è¯†çš„è´«ä¸‹ä¸­å†œç¤¾å‘˜ä¸­ï¼Œæ²¡æœ‰ä¸€ä¸ªä¸...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ogl2nfswm/">
    
    
    
    
    
      
    
    é‚“å…¬çš„å¾ˆå¤šä¸»å¼ ï¼Œæ°‘é—´å¹¶ä¸çŸ¥é“ã€‚æ˜¯æ‰¹é‚“åå‡»å³å€¾ç¿»æ¡ˆé£æŠŠè¿™äº›ä¸»å¼ æ˜­å‘Šå¤©ä¸‹ï¼Œè®©å¹¿å¤§äººæ°‘çŸ¥é“äº†é‚“å…¬çš„ä¼Ÿå¤§ã€‚æˆ‘é‚£æ—¶åœ¨å†œæ‘æ’é˜Ÿ ï¼Œè®¤è¯†çš„è´«ä¸‹ä¸­å†œç¤¾å‘˜ä¸­ï¼Œæ²¡æœ‰ä¸€ä¸ªä¸è¯´é‚“å…¬çš„ä¸»å¼ å¥½ã€‚é‚“å…¬è¯´ä»Šåå†œæ°‘æ€çŒªä¸ç”¨å–ä¸€åŠç»™å›½å®¶ï¼ŒåŸé•‡çŒªè‚‰æ•å¼€ä¾›åº”ã€‚å½“æ—¶æä¸æ‡‚ï¼Œå†œæ°‘ä¸å–çŒªè‚‰ç»™å›½å®¶ï¼ŒåŸé•‡å±…æ°‘å®šé‡ä¾›åº”å¦‚ä½•ä¿éšœï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å››å·é™ˆç„•ä»<!-- raw HTML omitted -->:â€‚ã€æ¯›ä¸»å¸­ç—…å±ä¹‹æ—¶æ€èµ·æ— åŠ›çš„æ‰¹é‚“åå‡»å³å€¾ç¿»æ¡ˆé£ã€‘ Ok.1976å¹´2æœˆ25æ—¥ï¼Œä¸­å…±ä¸­å¤®å¬å¼€å„çœå¸‚ã€è‡ªæ²»åŒºå’Œå„å¤§å†›åŒºè´Ÿè´£äººæ‰“æ‹›å‘¼ä¼šè®®ï¼Œé’ˆå¯¹å…¨å›½æ™®éå­˜åœ¨çš„â€œä¸èƒ½æ­£ç¡®å¯¹å¾…æ–‡åŒ–å¤§é©å‘½â€é—®é¢˜ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OgnA33nAX">ç¬¬ä¸€æ¬¡å¬è¯´ï¼Œå±…ç„¶æœ‰ä¸ªå…¨å›½â€œçˆ±å‘æ—¥â€ã€‚æˆ‘ç°åœ¨67&#43;å²ï¼Œä¾ç„¶é»‘å‘èŒå£®ï¼Œæ²¡æœ‰ç™½å‘ï¼Œæ›´æ²¡è„±å‘ã€‚æŠ¤å‘ç§˜è¯€ï¼šå¤©å¤©ä¸‹å¨ç‚’èœã€‚ - è½¬å‘ @å¤®è§†ç½‘:&amp;ensp;ã€#å…¨å›½çˆ±å‘æ—¥ä½ çš„å¤´å‘...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ogna33nax/">
    
    
    
    
    
      
    
    ç¬¬ä¸€æ¬¡å¬è¯´ï¼Œå±…ç„¶æœ‰ä¸ªå…¨å›½â€œçˆ±å‘æ—¥â€ã€‚æˆ‘ç°åœ¨67+å²ï¼Œä¾ç„¶é»‘å‘èŒå£®ï¼Œæ²¡æœ‰ç™½å‘ï¼Œæ›´æ²¡è„±å‘ã€‚æŠ¤å‘ç§˜è¯€ï¼šå¤©å¤©ä¸‹å¨ç‚’èœã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å¤®è§†ç½‘<!-- raw HTML omitted -->:â€‚ã€<!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Ogq8pAoYx">å¦‚æœå•ä»ç‰©è´¨å±‚é¢è¯´ï¼Œç°åœ¨å¹´è½»äººæ¯”æˆ‘ä»¬è¿™ä»£â€œ50åâ€å¹¸ç¦ç™¾å€ï¼Œä½†å´è¶Šæ´»è¶Šç´¯ã€‚ä¸ºä»€ä¹ˆï¼Ÿäººç”Ÿæœ¬æ¥å¾ˆç®€å•ï¼Œæƒ³å¤ªå¤šäº†ã€‚ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ogq8paoyx/">
    
    
    
    
    
      
    
    å¦‚æœå•ä»ç‰©è´¨å±‚é¢è¯´ï¼Œç°åœ¨å¹´è½»äººæ¯”æˆ‘ä»¬è¿™ä»£â€œ50åâ€å¹¸ç¦ç™¾å€ï¼Œä½†å´è¶Šæ´»è¶Šç´¯ã€‚ä¸ºä»€ä¹ˆï¼Ÿäººç”Ÿæœ¬æ¥å¾ˆç®€å•ï¼Œæƒ³å¤ªå¤šäº†ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;im &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OgkE7vNNP">çœ‹çœ‹ä¼šä¸ä¼šğŸˆ¶åŒæ ‡ğŸ‘¿</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ogke7vnnp/">
    
    
    
    
    
      
    
    çœ‹çœ‹ä¼šä¸ä¼šğŸˆ¶åŒæ ‡ğŸ‘¿  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OgkX0mTFE">æˆ‘æ„Ÿè§‰æˆ‘ç°åœ¨æ˜¯åŒæ—¶ä¸­äº†æ¯’ç‹—å¤§ã€å‰§æ¯’å¤§ã€æœ«æ—¥å¤§ã€æ¯’é¾™å¤§ã€‚</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ogkx0mtfe/">
    
    
    
    
    
      
    
    æˆ‘æ„Ÿè§‰æˆ‘ç°åœ¨æ˜¯åŒæ—¶ä¸­äº†æ¯’ç‹—å¤§ã€å‰§æ¯’å¤§ã€æœ«æ—¥å¤§ã€æ¯’é¾™å¤§ã€‚  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OglLne7mc">å†·é™æé—®ï¼šå°ç”³å’Œè€æœ´è°å…ˆå…«ç½ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ogllne7mc/">
    
    
    
    
    
      
    
    å†·é™æé—®ï¼š<!-- raw HTML omitted -->å°ç”³å’Œè€æœ´è°å…ˆå…«ç½ï¼Ÿ  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/Ogmr8BJbL">æ‰‹æœºå‚å•†ä½ åäº‹åšå°½[äºŒå“ˆ] [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ogmr8bjbl/">
    
    
    
    
    
      
    
    æ‰‹æœºå‚å•†ä½ åäº‹åšå°½<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgmbNrA2E">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.05.28 12:54ã€Œè¯¶å˜¿å˜¿ã€å‘¼å‘¼å‘¼ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogmbnra2e/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%25E">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgmbQaAtb">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.05.28 09:41ã€Œå“‡ã€æ—©ä¸Šå¥½ã€œä»Šå¤©æ•´å¤©éƒ½æœ‰æ‹æ‘„å“¦ä¼šåŠªåŠ›çš„å“¦æ—©ä¸Šå¼€å§‹å°±å› ä¸ºå¥½åƒçš„é¥­å›¢çœ‹èµ·æ¥...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogmbqaatb/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=23">https://m.weibo.cn/search?containerid=23</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgnbBpaeH">é€æˆ‘ - è½¬å‘ @éº¦å½“åŠ³:&amp;ensp;99%çœŸæ¦´è²æ·»åŠ ï¼ï¼ï¼æœ‰ä¸€æ¬¾éº¦æ—‹é£ï¼Œ5.29æ¥æŠ¥æ©[èˆ”å±]è¯„è®ºåŒºæ‹¿å‡ºã€ŒğŸ¥„ã€æ’ç»ƒä¸€ä¸‹ï¼ŒæŠ“ä¿©è¯·åƒï¼ï¼ˆ30å…ƒé¤åˆ¸ï¼Œ2ä½ï¼‰ éº¦å½“åŠ³çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ognbbpaeh/">
    
    
    
    
    
      
    
    é€æˆ‘<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@éº¦å½“åŠ³<!-- raw HTML omitted -->:â€‚99%çœŸæ¦´è²æ·»åŠ ï¼ï¼ï¼æœ‰ä¸€æ¬¾éº¦æ—‹é£ï¼Œ5.29æ¥æŠ¥æ©<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->è¯„è®ºåŒºæ‹¿å‡ºã€ŒğŸ¥„ã€æ’ç»ƒä¸€ä¸‹ï¼ŒæŠ“ä¿©è¯·åƒï¼ï¼ˆ30å…ƒé¤åˆ¸ï¼Œ2ä½ï¼‰ <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.png%22">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgreK3Ho5">å¥½æƒ³å’Œå§å§ä¸€ç›´åœ¨ä¸€èµ·</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogrek3ho5/">
    
    
    
    
    
      
    
    å¥½æƒ³å’Œå§å§ä¸€ç›´åœ¨ä¸€èµ·  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgrgyCnRy">å¹´åˆä¸€ç›´åœ¨è¯´å‡ºå›½ä¹‹ç±»çš„äº‹æƒ…æƒ³åˆ°åœ¨å›½å¤–æ²¡æœ‰å§å§å¦¹å¦¹æˆ‘è‚¯å®šä¼šå“­ç„¶åå°±æ˜¯æˆ‘ä»¬è¿™å„¿å·æ¸¡å¤ªå¤šè¢«é™åˆ¶å‡ºå¢ƒäº†æŠ¤ç…§è‡³ä»Šè¿˜æå¤§ä½¿é¦†å‹ç€åŒæ—¶ä¹Ÿå¯¼è‡´æˆ‘å»ä¸äº†é¦™æ¸¯æƒ³æƒ³æˆ‘çœŸçš„ç¦»...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogrgycnry/">
    
    
    
    
    
      
    
    å¹´åˆä¸€ç›´åœ¨è¯´å‡ºå›½ä¹‹ç±»çš„äº‹æƒ…<!-- raw HTML omitted -->æƒ³åˆ°åœ¨å›½å¤–æ²¡æœ‰å§å§å¦¹å¦¹æˆ‘è‚¯å®šä¼šå“­<!-- raw HTML omitted -->ç„¶åå°±æ˜¯æˆ‘ä»¬è¿™å„¿å·æ¸¡å¤ªå¤šè¢«é™åˆ¶å‡ºå¢ƒäº†<!-- raw HTML omitted -->æŠ¤ç…§è‡³ä»Šè¿˜æå¤§ä½¿é¦†å‹ç€<!-- raw HTML omitted -->åŒæ—¶ä¹Ÿå¯¼è‡´æˆ‘å»ä¸äº†é¦™æ¸¯<!-- raw HTML omitted -->æƒ³æƒ³æˆ‘çœŸçš„ç¦»ä¸å¼€æˆ‘å§<!-- raw HTML omitted -->å°±ç®—ç°åœ¨æˆ‘ä»¬åªé—´éš”40å‡ å…¬é‡Œ<!-- raw HTML omitted -->åªè¦æˆ‘æƒ³è§å¥¹æˆ‘å°±å¯ä»¥æ‰¾ä¸€ä¸ªå€Ÿå£å»è§å¥¹<!-- raw HTML omitted -->å°±æ˜¯è¿™ä¹ˆè¿‘çš„è·ç¦»<!-- raw HTML omitted -->ç”šè‡³æ˜æ˜æˆ‘ä»¬å¤§å‰å¤©æ‰è§è¿‡<!-- raw HTML omitted -->ä½†æ˜¯ç°åœ¨å°±æ˜¯å¾ˆæƒ³å¥¹ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgkRjlFi7">æ£‹æ‰‹æˆ˜é¹°åŸæ¥4ä½æ•°æ˜¯è¿™ä¹ˆæ˜¾ç¤ºçš„ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogkrjlfi7/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æ£‹æ‰‹æˆ˜é¹°<!-- raw HTML omitted --><!-- raw HTML omitted -->åŸæ¥4ä½æ•°æ˜¯è¿™ä¹ˆæ˜¾ç¤ºçš„ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Ogmsfetlh">æ—¥æœ¬å¥³å­å›´æ£‹è”èµ›ï¼Œé€‰ç§€ç¬¬ä¸€è½®æƒ…å†µï¼ˆæ‹¬å·ä¸ºæŠ½ç­¾å¤±è´¥æ—¶é€‰æ‹©çš„æ£‹æ‰‹ï¼‰å›´æ£‹å°†æ£‹é¢‘é“ï¼šè—¤æ³½é‡ŒèœSENKO Groupï¼šä¸Šé‡çˆ±å’²ç¾è‹¥é²¤ï¼šä¸Šé‡æ¢¨çº±ï¼ˆä¸Šé‡çˆ±å’²ç¾ï¼‰ç¦å†ˆï¼šè°¢ä¾æ—»ï¼ˆ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogmsfetlh/">
    
    
    
    
    
      
    
    æ—¥æœ¬å¥³å­å›´æ£‹è”èµ›ï¼Œé€‰ç§€ç¬¬ä¸€è½®æƒ…å†µï¼ˆæ‹¬å·ä¸ºæŠ½ç­¾å¤±è´¥æ—¶é€‰æ‹©çš„æ£‹æ‰‹ï¼‰<!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹å°†æ£‹é¢‘é“ï¼šè—¤æ³½é‡Œèœ<!-- raw HTML omitted -->SENKO Groupï¼šä¸Šé‡çˆ±å’²ç¾<!-- raw HTML omitted -->è‹¥é²¤ï¼šä¸Šé‡æ¢¨çº±ï¼ˆä¸Šé‡çˆ±å’²ç¾ï¼‰<!-- raw HTML omitted -->ç¦å†ˆï¼šè°¢ä¾æ—»ï¼ˆè—¤æ³½é‡Œèœã€ä¸Šé‡çˆ±å’²ç¾ï¼‰<!-- raw HTML omitted -->åå¤å±‹ï¼šåŠ è—¤åƒç¬‘<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/phot">https://n.sinaimg.cn/phot</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgmsLi6jY">æ—¥æœ¬å¥³å­å›´æ£‹è”èµ›ï¼Œé€‰ç§€ç¬¬äºŒè½®æƒ…å†µï¼ˆæ‹¬å·ä¸ºæŠ½ç­¾å¤±è´¥æ—¶é€‰æ‹©çš„æ£‹æ‰‹ï¼‰å›´æ£‹å°†æ£‹é¢‘é“ï¼šæ˜Ÿåˆå¿—ä¿SENKO Groupï¼šç‰›è£å­è‹¥é²¤ï¼šå¥¥ç”°å½©ï¼ˆç‰›è£å­ï¼‰ç¦å†ˆï¼šæŸ³åŸå’²è¾‰ï¼ˆæ˜Ÿåˆå¿—ä¿...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogmsli6jy/">
    
    
    
    
    
      
    
    æ—¥æœ¬å¥³å­å›´æ£‹è”èµ›ï¼Œé€‰ç§€ç¬¬äºŒè½®æƒ…å†µï¼ˆæ‹¬å·ä¸ºæŠ½ç­¾å¤±è´¥æ—¶é€‰æ‹©çš„æ£‹æ‰‹ï¼‰<!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹å°†æ£‹é¢‘é“ï¼šæ˜Ÿåˆå¿—ä¿<!-- raw HTML omitted -->SENKO Groupï¼šç‰›è£å­<!-- raw HTML omitted -->è‹¥é²¤ï¼šå¥¥ç”°å½©ï¼ˆç‰›è£å­ï¼‰<!-- raw HTML omitted -->ç¦å†ˆï¼šæŸ³åŸå’²è¾‰ï¼ˆæ˜Ÿåˆå¿—ä¿ï¼‰<!-- raw HTML omitted -->åå¤å±‹ï¼šç‹æ™¯æ€¡<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/2018092">https://n.sinaimg.cn/photo/5213b46e/2018092</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgmtD4Ybh">æ—¥æœ¬å¥³å­å›´æ£‹è”èµ›å‰ä¸‰è½®é€‰ç§€æƒ…å†µ#å›´æ£‹#å›´æ£‹ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogmtd4ybh/">
    
    
    
    
    
      
    
    æ—¥æœ¬å¥³å­å›´æ£‹è”èµ›å‰ä¸‰è½®é€‰ç§€æƒ…å†µ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgmxR3jup">ç¬¬ä¸€å±Šæ—¥æœ¬å¥³å­å›´æ£‹è”èµ›å„é˜Ÿäººé€‰æƒ…å†µå›´æ£‹å°†æ£‹é¢‘é“ï¼šè—¤æ³½é‡Œèœã€æ˜Ÿåˆå¿—ä¿ã€å¾æ–‡ç‡•ã€é«˜å±±å¸Œå¸ŒèŠ±SENKO Groupï¼šä¸Šé‡çˆ±å’²ç¾ã€ç‰›è£å­ã€ä¸‡æ³¢å¥ˆç©—ã€äº•æ³½ç§‹ä¹ƒè‹¥é²¤ï¼šä¸Šé‡æ¢¨...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogmxr3jup/">
    
    
    
    
    
      
    
    ç¬¬ä¸€å±Šæ—¥æœ¬å¥³å­å›´æ£‹è”èµ›å„é˜Ÿäººé€‰æƒ…å†µ<!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹å°†æ£‹é¢‘é“ï¼šè—¤æ³½é‡Œèœã€æ˜Ÿåˆå¿—ä¿ã€å¾æ–‡ç‡•ã€é«˜å±±å¸Œå¸ŒèŠ±<!-- raw HTML omitted -->SENKO Groupï¼šä¸Šé‡çˆ±å’²ç¾ã€ç‰›è£å­ã€ä¸‡æ³¢å¥ˆç©—ã€äº•æ³½ç§‹ä¹ƒ<!-- raw HTML omitted -->è‹¥é²¤ï¼šä¸Šé‡æ¢¨çº±ã€å¥¥ç”°å½©ã€é“ƒæœ¨æ­¥ã€å¤§æ£®å…°<!-- raw HTML omitted -->ç¦å†ˆï¼šè°¢ä¾æ—»ã€æŸ³åŸå’²è¾‰ã€å‘äº•åƒç‘›ã€è¾»å<!-- raw HTML omitted -->åå¤å±‹ï¼šåŠ è—¤åƒç¬‘ã€ç‹æ™¯æ€¡ã€é«˜é›„èŒ‰è‰ã€ç¾½æ ¹å½©å¤<!-- raw HTML omitted --><!-- raw HTML omitted -->ç¬¬ä¸€è½®å°†äº7æœˆ17æ—¥è¿›è¡Œï¼Œå¸¸è§„èµ›å°†è¿›è¡Œè‡³æ˜å¹´5æœˆï¼Œå¥³å­è”èµ›å®˜ç½‘å°†åœ¨è¿‘æœŸå…¬å¼€ã€‚ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgnrL8mGK">æˆ‘ä¸å¤ªäº†è§£ç”µå½±ï¼Œæˆ‘åªæ˜¯è§‰å¾—æ—¥æœ¬äººå¥½åƒè¦æ‹èµ›åšå›´æ£‹äº†#å›´æ£‹#å›´æ£‹ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ognrl8mgk/">
    
    
    
    
    
      
    
    æˆ‘ä¸å¤ªäº†è§£ç”µå½±ï¼Œæˆ‘åªæ˜¯è§‰å¾—æ—¥æœ¬äººå¥½åƒè¦æ‹èµ›åšå›´æ£‹äº†<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot;  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgntHqmkC">å›å¤@ç”¨æˆ·7910485869:éŸ©å›½æ¯”èµ›æŒºå¤šï¼Œåˆšæ‹¿åˆ°å¤–å¡ è¯„è®ºé…å›¾ //@ç”¨æˆ·7910485869:ä»²é‚‘å ‡å‘¢ - è½¬å‘ @æ‰¾å€Ÿå£å®‰é™:&amp;ensp;ç¬¬ä¸€å±Šæ—¥æœ¬å¥³å­å›´æ£‹è”èµ›å„é˜Ÿäººé€‰æƒ…å†µå›´æ£‹å°†æ£‹é¢‘...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ognthqmkc/">
    
    
    
    
    
      
    
    å›å¤<!-- raw HTML omitted -->@ç”¨æˆ·7910485869<!-- raw HTML omitted -->:éŸ©å›½æ¯”èµ›æŒºå¤šï¼Œåˆšæ‹¿åˆ°å¤–å¡ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->è¯„è®ºé…å›¾<!-- raw HTML omitted --><!-- raw HTML omitted --> //&lt;a href=&ldquo;<a href="https://weibo.com/n/%E7%94%A8%E6%88%B7791048">https://weibo.com/n/%E7%94%A8%E6%88%B7791048</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgqylmPDO">å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€ŠæŒ«æŠ˜å’Œæ”¹è¿‡è‡ªæ–°â€”â€”èµµæ²»å‹‹ã€Šæˆ‘çš„å±¥å†ä¹¦ã€‹ï¼ˆ6ï¼‰ã€‹ #å›´æ£‹# å›´æ£‹ æŒ«æŠ˜å’Œæ”¹è¿‡è‡ªæ–°â€”â€”èµµæ²»å‹‹ã€Šæˆ‘çš„å±¥å†ä¹¦ã€‹ï¼ˆ6ï¼‰ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogqylmpdo/">
    
    
    
    
    
      
    
    å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€ŠæŒ«æŠ˜å’Œæ”¹è¿‡è‡ªæ–°â€”â€”èµµæ²»å‹‹ã€Šæˆ‘çš„å±¥å†ä¹¦ã€‹ï¼ˆ6ï¼‰ã€‹ <!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OglTYAP1I">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.05.28 12:54ã€Œè¯¶å˜¿å˜¿ã€å‘¼å‘¼å‘¼ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogltyap1i/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OglXKl0ke">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.05.28 09:41ã€Œå“‡ã€æ—©ä¸Šå¥½ã€œä»Šå¤©æ•´å¤©éƒ½æœ‰æ‹æ‘„å“¦ä¼šåŠªåŠ›çš„å“¦æ—©ä¸Šå¼€å§‹å°±å› ä¸ºå¥½åƒçš„é¥­å›¢çœ‹èµ·æ¥å¤ªå¥½åƒäº†ï¼Œåƒäº†ä¸¤ä¸ªã€‚å†åƒäº†ä¸€ä¸ªä¸‰...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oglxkl0ke/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgpRwpg8l">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# .è™½ç„¶å–œæ¬¢è¯è¯­ï¼Œä½†å¶å°”ï¼Œåªæ˜¯å¶å°”ï¼Œæˆ‘ä¸ä¼šç›¸ä¿¡è¯è¯­ã€‚ä¸æ˜¯ã€é‚£æ—¶ï¼Œä½ æ˜æ˜æ˜¯è¿™ä¹ˆè¯´çš„ã€‚ã€ï¼Œè€Œæ˜¯æƒ³ç›¸ä¿¡ä½ ã€‚ä¿æŒè¿™æ ·çš„å¿ƒæƒ…æ˜¯å¤šä¹ˆç¾å¥½å‘¢ã€‚â˜º...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogprwpg8l/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shio &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6117592326/OgraRFydZ">å²ä¸Šæœ€æ…¢å·¡ç¤¼[äºŒå“ˆ] å¾·å›½Â·æœå¡å°”å¤šå¤«è€åŸ Schweinske [å›¾ç‰‡][å›¾ç‰‡] [Live Photo][Live Photo]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6117592326-ograrfydz/">
    
    
    
    
    
      
    
    å²ä¸Šæœ€æ…¢å·¡ç¤¼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å¾·å›½Â·æœå¡å°”å¤šå¤«è€åŸ Schweinske<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006G0NdYgy1hq5nuyrb9yj30xx1gsanh.jpg%22">https://tvax2.sinaimg.cn/large/006G0NdYgy1hq5nuyrb9yj30xx1gsanh.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OgpsDkCoD">æŸ¯æ´#2024ä¹å±…ä¹æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›##èµ›äº‹é¢„å‘Š# 2024ä¹å±…ä¹æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›å¸¸è§„èµ›ç¬¬äºŒè½®å°†äºæ˜å¤©ä¸­åˆåäºŒç‚¹åœ¨æµ™æ±Ÿé•¿å…´è¿›è¡Œï¼ŒæŸ¯æ´ä¹æ®µå¯¹é˜µæç»´æ¸…ä¹æ®µã€‚ä¸¤é˜Ÿå¯¹...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ogpsdkcod/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extpara">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extpara</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1cM4m1r779">ã€è´ºå–œç»ƒå•è½¦ã€‘ 2024.05.28 è´ºå–œé¥é¦™ åŠå°æ—¶é—²èŠç›´æ’­</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1cm4m1r779/">
    
    
    
    
    
      
    
    è´ºå–œç»ƒå•è½¦
æ—¶éš”444å¤©åï¼Œçœ¼é•œå¨˜é¦–æ¬¡å±•éœ²äºé•œå¤´å‰è¿›è¡Œç›´æ’­ï¼Œä½ ä¸çœ‹è¡Œå—ï¼ï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/547356148/answer/3512862980">é‡å­ä½å›ç­”äº†é—®é¢˜: é¥®æ–™ç³–æœä¸­æ°´æœé¦™ç²¾çš„å‘³é“å’ŒçœŸå®æ°´æœç›¸å·®ç”šè¿œï¼Œåœ¨åˆ¶ä½œçš„æ—¶å€™æ˜¯æ€ä¹ˆè”æƒ³èµ·æ¥çš„ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-547356148-answer-3512862980/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/654212165/answer/3512521009">é‡å­ä½å›ç­”äº†é—®é¢˜: ä¼ é©¬æ–¯å…‹æ——ä¸‹AIå…¬å¸å°†å®Œæˆ 60 äº¿ç¾å…ƒèèµ„ï¼Œå®ƒå®åŠ›æ€ä¹ˆæ ·ï¼Ÿèƒ½æ¯”å¾—è¿‡openAIå—ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-654212165-answer-3512521009/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/655908713/answer/3503680826">ä¹Œé¸¦æ ¡å°‰èµåŒäº†å›ç­”: å·¦æ´¾ä¼šå¦‚ä½•çœ‹å¾…çš‡æ±‰ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-655908713-answer-3503680826/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/657415147/answer/3513012280">å¼ æ•¬ä¿¡å›ç­”äº†é—®é¢˜: Rè¯­è¨€å‰”é™¤æ•°å­—çš„åŠæ³•ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-657415147-answer-3513012280/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700263571">é‡å­ä½å‘è¡¨äº†æ–‡ç« : å¤šæ¨¡æ€CoTæ€ç»´é“¾æ¶æ„æ¥äº†ï¼Œç°å·²å¼€æºï½œæ¥è‡ªå¦å¤§&amp;è…¾è®¯ä¼˜å›¾</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700263571/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700265888">é‡å­ä½å‘è¡¨äº†æ–‡ç« : å›½äº§å¼€æºSoraä¸Šæ–°ï¼šå…¨é¢æ”¯æŒå›½äº§AIç®—åŠ›ï¼Œå¯ç”¨ReVideoè§†é¢‘ç¼–è¾‘ï¼ŒåŒ—å¤§-å…”å±•å›¢é˜Ÿå‡ºå“</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700265888/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700269480">é‡å­ä½å‘è¡¨äº†æ–‡ç« : é€é™…åŠ¨åŠ›å¼ åŠ›ï¼šäººå½¢æœºå™¨äººåº”è¯¥ä»£æ›¿äººç±»ï¼Œè€Œä¸æ˜¯ä»£æ›¿å·¥å…·</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700269480/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700280905">é‡å­ä½å‘è¡¨äº†æ–‡ç« : æœ€éš¾æ–¹è¨€æ¸©å·è¯è¢«æ”»å…‹ï¼ä¸­å›½ç”µä¿¡è¯­éŸ³å¤§æ¨¡å‹æ”¯æŒ30ç§æ–¹è¨€ï¼Œè¿™é¢˜GPT-4oå¯ä¸ä¼šåšå•Š</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700280905/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700335238">é‡å­ä½å‘è¡¨äº†æ–‡ç« : ç›®æ ‡æ£€æµ‹æ–°SOTAï¼Œç«¯ä¾§å®æ—¶è¯†åˆ«ï¼Œæ²ˆå‘æ´‹ç½•è§è½¬å‘ç‚¹èµ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700335238/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700364821">ç‹è¯—ç¿”å‘è¡¨äº†æ–‡ç« : é€‚åˆç©äº‘çš„æ—¶å€™åˆæ¥äº†</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-28</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700364821/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

